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Abstract 
The fight against antimicrobial resistance needs new weapons. Bacteria resistant to 
all known antibiotics are anticipated to cause 10 million deaths by 2050. A series of novel 
Supramolecular Self-Associating Amphiphiles have been synthesised to add to the arsenal; 
either as unique antimicrobial agents or to act as drug delivery agents. The self-association 
properties of these compounds were studied in the gas phase, solid state and solution state 
using a range of physicochemical studies. These experiments included: electron spray 
ionisation mass spectrometry, single crystal X-ray diffraction, quantitative 1H NMR, diffusion 
ordered spectroscopy, tensiometry, dynamic light scattering and zeta potential. One of the 
novel compounds was observed to form hydrogels in aqueous salt solutions, and these gels 
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q  quartet (NMR) 
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S. aureus Staphylococcus aureus 
SSA  Supramolecular self-associating amphiphiles 
t  triplet (NMR) 
TBA  Tetrabutylammonium 
TFA  Trifluoroacetic acid 
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1.1. Supramolecular chemistry 
The term “Supramolecular chemistry” was coined in 1969 by Jean-Marie Lehn, and 
defined as “chemistry beyond the molecule”.1,2 Supramolecular chemistry is a branch of 
chemistry concerned with higher order complexes that occur as a result of non-covalent 
intermolecular forces between molecules.3 Lehn, together with Charles Pederson and Donald 
Cram were awarded a Nobel Prize in chemistry in 1987 for this work.4 Since this time, the 
field of supramolecular chemistry has continued to evolve, resulting in another Nobel Prize 
in chemistry in 2016. This prize was shared between Jean-Pierre Sauvage, Sir J. Fraser 
Stoddart and Bernard Feringa whose trail blazing work was in the field of molecular 
machines.5 Stoddart’s work on rotaxanes,6 building on work from Sauvage, showed that the 
supramolecular complexes could act as a motor, with a ring system able to move on an axle.7 
Further work utilising rotaxane-based motors led to the synthesis of synthetic muscles using 
the same principle; a ring system moving on an axle that can stretch and compress (Figure 
1).8 
 
Figure 1 – Example of a) a sarcomere (human muscle) contracting and expanding, orange represents 
myosin, green represents actin and b) rotaxane-based molecular muscle system. 
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Although the field of supramolecular chemistry is a relatively young innovation, non-
covalent interactions have been studied since Friedrich Wöhler first synthesised urea crystals 
from inorganic reactants (Scheme 1). This reaction could arguably be seen as the beginning 
of modern chemistry, occurring in the 17th centuary.9,10 At the time, the formation of organic 
compounds from inorganic reactants was thought to be impossible and went against the laws 
of vitalism, a theory abandoned in modern times, as inorganic compounds do not contain the 
energy for life.11 
 
Scheme 1 - Formation of an organic compound from inorganic compounds by Freidrich Wöhler.10 
The formation of organic compounds caused the field of organic chemistry to grow 
and develop through the 19th century, with theories of how atoms were bonded heavily 
disputed. In 1913 Gilbert Lewis proposed the idea of the covalent bond, the currently 
accepted model of atomic bonding.12 The covalent bond was described using the theory of 
“valence”, which uses dots and crosses to show lone and paired electrons and the bonds that 
form when these electrons are shared, as shown in Figure 2. The theory of valence described 
two different types of bonds: polar bonds which are formed through electron transfer; and 




Figure 2 – Example of a Lewis dot and cross diagram: a) an oxygen atom and two hydrogen atoms; b) 
a water molecule, with electrons being shared between the oxygen and hydrogens. 
1.2. Non-covalent interactions 
Non-covalent interactions were theorised before the theory of the covalent bond 
was fully accepted. Johannes Diderik van der Waals theorised the existence of intermolecular 
non-covalent interactions in 1873, now known as van der Waals interactions.15–17 In 1894 this 
theory led to Emil Fischer proposing that these non-covalent interactions were integral in the 
complex formed between an enzyme and substrate, known as the lock and key (or host-
guest) concept.18 The hypothesis was, a specific substrate (key/guest) possesses a 
complementary fit to the enzyme’s active site (lock/host). Non-covalent interactions form 
between the host and guest, lowering the activation barrier and allowing the chemical 
reaction to occur. The three-dimensional shape of the enzyme’s active site is held together 
by non-covalent interactions, which enable specific functions to be performed, allowing 
enzymes to act as catalysts. The lock and key principle led Tom Moore and Thomas Winmill 
to suggest the presence of the hydrogen bond.19 Wendell Latimer and Worth Rodebush 
developed this theory to show that the hydrogen bond is different from dipoles.20 A dipole is 
a bond or molecule whose ends have opposite charges. Hydrogen bonds only form between 
electronegative atoms and electropositive hydrogens, whereas dipoles form between any 
molecules with a net dipole. 
Non-covalent interactions do not share electrons and arise through electrostatic 
interactions between the distributions of electrons. These non-covalent interactions can 
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have bond energies as small as < 4 kJ mol-1 to 200 kJ mol-1 (comparable in strength to a 
covalent bond).20 Non-covalent interactions include:  
i) van der Waals interactions which are comparatively weak electrostatic 
interactions between nuclei caused by the polarisation of electron clouds 
(Figure 3a). They typically have energies of <4 kJ mol-1 and, though 
individually, van der Waals forces are small, the sum of the interactions can 
be large.21,22 
ii) Dipole-dipole interactions are the next weakest non-covalent interactions 
with energies of 5 – 50 kJ mol-1 and are formed through the attraction of one 
dipole to another (Figure 3b).21,23 
iii) π-π interactions occur between conjugated systems that have delocalised 
electrons due to multiple covalent bonds, and have energies between 0 - 50 
kJ mol-1. These can stack in three different ways: face to face; edge to face; 
or offset (Figure 3c).24 
iv) Hydrogen bonds have been extensively studied.25–27 They have an energy 
range of 4 - 165 kJ mol-1 and can have both covalent and non-covalent 
character (Figure 3d). They occur between hydrogen bond donor (HBD) and 
hydrogen bond acceptor (HBA) groups. 
v) Ion-dipole interactions occur between dipoles and charged ions, for example 
Na+ and water (50 - 200 kJ mol-1) (Figure 3e).28 
vi) Ion-ion interactions (Figure 3f) are the strongest type of non-covalent 
interaction with energies ranging from 10 - 350 kJ mol-1, comparable to that 




Figure 3 - Illustration of non-covalent interactions a) van der Waals; b) dipole-dipole; c) π-π 
interactions (edge to face, face to face and off-set respectively); d) hydrogen bond; e) ion-dipole; e) 
ion-ion. 
As stated previously, the hydrogen bond can have both covalent and non-covalent 
character, each with different energies.32–35 An important thing about hydrogen bonds is that 
they are highly directional and optimise at 180°. To form the different geometries, there has 
to be a pay out of energy to move away from linearity. This energy pay out is often the 
“additive effect”, leading to the different geometries. The variety of different geometries are 
shown in Figure 4.36 The length of hydrogen bonds (> 1.5 Å) is comparable to the length of 
the covalent bond (1.2 - 1.5 Å)33 but the strength of the bond is dependent on the HBA/HBD 
pair that are involved. The HBA groups are electronegative atoms including oxygen and 
nitrogen, which interact with the HBD, electropositive acidic hydrogen atoms, such as those 




Figure 4 - Examples of hydrogen bond geometries a) preferred linear geometry, b) bent, c) accepting 
bifurcated, d) donating bifurcated, e) trifurcated, f) three-centred bifurcated. Dashed red lines 
represent a hydrogen bond. 
Once these non-covalent interactions were beginning to be understood, a synthetic 
approach to host-guest supramolecular chemistry began. Pederson developed crown ethers 
(1),28 Lehn developed cryptands (2) and Cram developed macrocyclic cylophanes (3) as seen 
in Figure 5.37 These molecules are able to bind to metallic cations. 
 
Figure 5 - Series of host-guest complexes examples: 1 crown ether; 2 cryptate; and 3 spherand.16 
Supramolecular complexes are either preorganised, where they are designed with 
molecular rigidity to interact with a complementary molecule through non-covalent 
interactions, or can self-organise.38,39 Self-organised complexes involve self-assembly events, 
resulting in both lower and higher ordered complex units through predominantly non-
covalent intermolecular interactions.40,41 A molecule that can form supramolecular 
complexes can be designed to both be preorganised and to self-organise.42 
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1.3. Non-covalent interactions in nature 
Non-covalent interactions and resultant supramolecular complexation is abundant 
in nature. The characteristics of the hydrogen bonds that form in water allows many 
compounds to dissolve in high concentrations. At these high concentrations hydrogen bonds 
and/or dipole-dipole interactions can occur, which act as a stabilising force for 
macromolecules.43 Examples of supramolecular complexes found in nature include: proteins, 
which represent fundamental building blocks for all living creatures;44 DNA; and RNA. 
Proteins are built from amino acids, a general unit with an R group that can change 
the property of the amino acid, and therefore the protein, as shown in Figure 6. 
 
Figure 6 – General structure of an amino acid. 
An R group can confer different chemical properties: polar; non-polar; acidic, basic; 
and aromatic.45 Amino acids are joined together via peptide bonds (Scheme 2), and this chain 
of amino acids form the primary structure of the protein (Figure 7a), which then self-
assembles into secondary structures dependent on the R groups of the amino acids. 
 
Scheme 2 – A peptide bond formed via a condensation reaction (highlighted in orange). R1 = serine 
(polar); R2 = alanine (non-polar); R3 = histidine (acidic); R4 = aspartate (basic); R5 = phenylalanine 
(aromatic). 
These secondary structures include β-pleated sheets (Figure 7b), α-helices (Figure 
7c) and β-turns/coils and are formed depending on the sequence of amino acids in the 
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primary structure. The secondary structures are stabilised by hydrogen bonds between the 
peptide bonds.43,46,47 The higher structure of the protein brings amino acids which are not 
covalently joined, close together in space enabling the formation of non-covalent 
interactions and covalent disulfide bridges between R groups.48,49 The final three-dimensional 
conformation of an individual protein or peptide is the tertiary structure (Figure 7d). If a 
protein requires multiple peptide chains or co-factors these can come together to form a 
quaternary structure (Figure 7d). Quaternary structure formation can be driven by the 
hydrophobic effect, and is stabilised by a range of non-covalent interactions and covalent 
bonds.46 Hydrogen bonds, van der Waals interactions, electrostatic interactions, hydrophobic 
interactions and disulfide bridges all help stabilise protein structures.43,50–52 
 
Figure 7 – Different levels of structure of proteins: a) primary, the sequence of amino acids; b) beta 
sheets; c) alpha helix, which are both secondary structures; d) tertiary structure, the final structure of 
a peptide; e) quaternary structure, the final conformation of the protein. 
As previously discussed, in Fischer’s lock and key hypothesis, non-covalent 
interactions stabilise the enzyme and substrate complex. Another notable biological 
molecule that relies on non-covalent interactions is deoxyribonucleic acid (DNA). The 
structure of DNA was discovered by James Watson and Francis Crick, with Rosalind Franklin 
in 1953. Two antiparallel repeating strands of nucleotides interact to form a double helix 
(Figure 8).53 The number of hydrogen bonds that form between the nucleobases depends on 
the bases present; adenosine (A) and thymine (T) form two hydrogen bonds and cytosine (C) 
and guanine (G) form three. This difference in the number of hydrogen bonds can have a 
profound effect on the stability of the DNA. The strength of hydrogen bonds are additive, 
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therefore, DNA with higher GC content has higher stability.54 As well as hydrogen bonds 
between the bases, DNA utilises multiple non-covalent interactions, from the π-π 
interactions between bases on the same strand, van der Waals forces throughout the whole 
structure, to the hydrophilic interactions between the cytoplasm of the cell and the 
phosphate backbone. This molecule highlights the importance of non-covalent interactions, 
both in nature and within supramolecular chemistry. 
 
Figure 8 - Deoxyribonucleic acid (DNA) formed of nitrogenous bases (blue), deoxyribose sugar (purple) 
and phosphate (orange). Deoxyribose + base = nucleoside (green), nucleoside + phosphate = 
nucleotide (red). Multiple nucleotides = polynucleotide (yellow). Two antiparallel strands of 
polynucleotides = double stranded DNA (pink). 
1.4. Amphiphiles and Supra-amphiphiles 
An amphiphile has hydrophobic and hydrophilic components that are covalently 
bound.55 There are multiple ways of categorising amphiphiles. One depends on the nature of 
the hydrophilic group: zwitterionic; anionic; cationic; or nonionic (Figure 9).56 Zwitterionic 
amphiphiles (Figure 9, 4, POPC) carry both a positive and negative charge in the head group.57 
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Cationic amphiphiles (Figure 9, 5, SDS) carry a positively charged head group with a non-
amphiphilic counter anion.58 Anionic amphiphiles (Figure 9, 6, CTA) carry a negatively charged 
head group, often sulfonate, sulfate, phosphate or carboxylate with a non-amphiphilic 
counter cation.59 Nonionic amphiphiles (Figure 9, 7) carry no charge, their solubility depends 
on the functional group of the amphiphile and its acidity. The hydrophobic component of the 
amphiphile is typically a hydrocarbon chain, but aromatic rings and trifluoromethyl groups 
are also sufficiently hydrophobic.60,61 
 
Figure 9 - Examples of amphiphiles: zwitterionic (4); anionic (5); cationic (6); and nonionic (7). The 
hydrophilic area of the compound is highlighted in blue and is the head of the amphiphile, the anionic 
area is highlighted in green and the cationic in orange. The hydrophobic tail of the amphiphile is the 
hydrocarbon chain. 
Compound 4 can be found in the eukaryotic cell membrane, and makes up about half 
of all membrane lipids. 62 The cell membrane is a very important supramolecular complex 
found in nature and predominantly consist of phospholipid bilayers, which themselves are 
amphiphiles.62 The self-associating nature of amphiphiles is used as a tool by supramolecular 
chemists. 
One main feature of an amphiphile is its ability to aggregate to form multiple 
macromolecular structures dependent on the solvent system. Amphiphiles self-associate by 
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minimising non-preferential interactions and maximising preferential interactions within the 
solution state. This self-association allows the formation of many different structures, 
including reverse micelles (Figure 10a), micelles (Figure 10b), vesicles (Figure 10c), and lipid 
bilayers (Figure 10d).63,64 Reverse micelles (Figure 10a) are formed in non-polar solvents, 
where the tails interact with the non-polar solvent and the heads are encapsulated. Micelles 
(Figure 10b) form in aqueous solvents, as the hydrophilic head group interacts with the water 
molecules whilst the hydrophobic tails are enclosed away from the aqueous solvent. The 
structure of the amphiphile also influences which structures are formed, for example, 
amphiphiles with single hydrophobic hydrocarbon chains will predominantly form micelles 
or reverse micelles. However, amphiphiles with multiple hydrocarbon chains form vesicles 
(Figure 10c) due to the fact that the chains are too large to fit inside the micelle. 
Phospholipids form the bilayer (Figure 10d) in the membranes found in cells.63,64 
 
Figure 10 – a) Reverse micelle, b) micelle, c) vesicle, d) lipid bilayer. 
In 2009 Wang et al. published an extensive review on self-assembly using 
amphiphilicity.65 Whilst the focus of this review was on irreversible binding, the concept of 
self-assembly through non-covalent interactions was also explored. Supramolecular chemists 
have taken inspiration from nature and developed amphiphilic molecules that are capable of 
forming supramolecular complexes. These so called “supra-amphiphile” complexes utilise 
non-covalent interactions to self-assemble.56,66 These supra-amphiphiles are amphiphiles 
that are built on the principle of non-covalent interactions and dynamic covalent bonds.66,67 
A supra-amphiphile can also be formed by modifying the amphiphile with non-covalent 
interactions, thereby changing the physical properties (amphiphilicity). 68–70  
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Supra-amphiphile complexes are also formed using other non-covalent interactions. 
Zhang et al. synthesised supra-amphiphiles using wedge shaped amphiphiles that self-
assembled into spherical aggregates using π-π interactions (8, Figure 11).71 Kabanov et al. 
used electrostatic attraction between single-tail cation surfactants and an ionic head group 
which, when combined together, formed micelle-like aggregations (9, Figure 11).72 Metal-
ligand coordination can also be used as a driving force of assembly of supra-amphiphiles. 
Gohy et al. synthesized block co-polymers that self-assemble with ruthenium ions to form 
micelles in water (10 Figure 11).73 These examples of supra-amphiphile complexes use only 
one form of non-covalent bond, but in most cases, multiple different non-covalent 
interactions contribute to the driving force of self-assembly.66 
 
Figure 11 – Examples of supra-amphiphile complexes using different non-covalent interactions.71–73 
1.5. Incorporating host-guest chemistry into amphiphile design 
Host-guest chemistry is an area of chemistry involved in the complexation of two or 
more molecules/ions that are held together in a unique conformation. Non-covalent bonding 
is crucial in holding these resultant complexes. Hydrogen bonds are one of the most 
commonly found bonds in host-guest chemistry interactions. The urea motif (11, Figure 12) 
acts as a potent H-bond doner, enabling the entrapment of anions such as sulfonates, 
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phosphates and carboxylates.74 By increasing the acidity of the urea protons, which is 
accomplished by adding electron withdrawing groups in the form of conjugated ring systems, 
CF3 groups or NO2, the affinity to the guest can increase.75 
 
Figure 12 – The urea motif showing the three hydrogen bonds that can form. 
The use of hydrogen bonds in supra-amphiphiles has been discussed, and one 
method of utilising them is to incorporate hydrogen bonding into the molecular design. For 
example using HBA and HBD groups as shown in 12 and 13 (Figure 13).76,77 Kimizuka et al. 
synthesised 12 and 13 to form synthetic bilayer membranes using hydrogen bonds. Whilst 
the individual components are insoluble in water, when they are mixed they become soluble 
and form “croissant like” aggregates.77  
 
Figure 13 – Example of a supra-amphiphile with incorporated HBA and HBD groups.77 
The urea motif has also been used in other areas of supramolecular chemistry. 
Faustino et al. utilised it in their work in surfactant amino acids (14, Figure 14).78–80 These 
researchers found that the compounds had critical micelle concentrations (CMC) that were 
competitive with other carboxylate surfactants. The contending CMC was attributed to the 
hydrogen bonding properties of the urea functionality.79 
 
Figure 14 - The use of the urea motif in surfactants.79 
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Drawing on the work of Faustino et al., Hiscock et al. incorporated the use of the urea 
functionality into their family of “Supramolecular Self-associating Amphiphiles” (SSAs). The 
general structure of the SSA can be seen in Figure 15: an anionic HBA group; a urea group; 
and a hydrophobic region. The hydrophobic region contains R groups which change the 
acidity of the amines, an idea first seen in 15 – 18.81,82  
 
Figure 15 – General structure of frustrated amphiphile system, reported by Hiscock et al..83 
 
Figure 16 - Urea functionalities used in conjunction to π-π interactions.81,82 
The SSA can adopt four different binding modes leading to a “frustrated” system. The 
different binding modes include tapes (Figure 17a) and dimers (Figure 17b) whilst binding 
through urea-anion, or stacking modes, both syn- (Figure 17c) and anti- (Figure 17d) through 
urea-urea binding.83,84 The frustrated system is due to there being only one HBD group (the 
NHs in the urea functionality) and two different HBA groups (the O in the urea functionality 
and the X anion). The binding modes of the system are dependent on the solvent system, the 
physical state, the counter cation and the chemical composition of the compound. The 




Figure 17 – Possible modes of self-association of the amphiphiles. a) tape, b) dimer, c) syn-stacking, d) 
anti-stacking. 
To define the structure-activity relationship of self-association, Hiscock et al. 
expanded the family of SSAs, whilst keeping the general structure of the amphiphile the same 
(Figure 15).85 The R groups on the aromatic ring were modified, adding both electron 
withdrawing and donating groups. Analogues were synthesised, replacing urea for thiourea, 
sulfonate for carboxylate, and different cations that co-ordinated with different strengths. 
Further to this, the self-association properties of these compounds were studied in the solid 
state, gas phase, solution state and in silico.86 
Hiscock et al. used electron spray ionisation mass spectrometry (ESI-MS) of the 
anionic component and found that a proportion of the compounds self-associated in the gas 
phase to form dimers.86 Using single crystal X-ray diffraction (XRD), they were able to visualise 
different stacking modes within the solid state: dimers with different interior angles of self-
association; hydrogen bonded tapes; and larger extended structures, such as pseudo water 
channels.83–85 In the solution state, the self-association depends on the solvent. In dimethyl 
sulfoxide (DMSO), the compounds predominantly form dimers, whereas in EtOH:H2O 1:19 
primarily spherical aggregates are formed with a range of sizes (91 - 460 nm).85 They used a 
variety of NMR experiments and other solution state studies to study the association events. 
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These experiments include: quantitative 1H NMR; dilution studies; diffusion ordered 
spectroscopy (DOSY); dynamic light scattering (DLS); zeta potential; and CMC (all further 
explained in Section 2). To allow visualisation of the structures using fluorescence 
microscopy, an intrinsically fluorescent group (benzothiazole or anthracene) was added to 
the SSA.86 Hiscock et al. have also synthesised DNA inspired molecules to investigate the 
formation of extended structures of the SSAs due to the complementarity of the inspired 
compounds.87,88 The SSAs have also been shown to have antimicrobial activity against 
clinically relevant gram-negative and gram-positive bacteria.89,90 
Most recently, Hiscock et al. found that 19 (Figure 18) formed hydrogels in 15 
different salt solutions.90 The researchers found that when the SSAs were dissolved in H2O, 
stable spherical aggregates were formed and, although the zeta potential for these 
aggregates was -71 mV (stable)91,92 when additional salts were added, a hydrogel was formed. 
It was concluded that the added salt was responsible for the higher order structures that 
produced the gel fibres. The properties of the hydrogel in the different salt solutions were 
characterised, including the minimum gelation concentration, pH and melting point. Hiscock 
et al. used rheology to find the comparative storage (G’) and loss (G”) modulus, which are 
used find the energy needed to untangle the gel fibres.90,93 The researchers found the SSAs 
had an increased efficacy to MRSA over E. coli which they hypothesised was due to 
differences in phospholipid composition and the presence of the single phospholipid 
bilayer.90 Hiscock et al. also found that the SSA hydrogelator (19) could be added to an 
ampicillin NaCl salt, which greatly increased the zone of inhibition, adding to the usability of 
the hydrogels as potential drug transportation.90 
 
Figure 18 – Original SSA gelator.90 
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The next steps are to determine the structure activity relationship of gelation. This 
project will focus on stepwise modifications of the general SSA structure to produce next 
generation SSAs, to further aid understanding of the structure-activity relationship of 
gelation. 
1.6. Project aims and objectives 
1.6.1. Project aim 
To produce new molecular weapons in the fight against antimicrobial resistance. 
1.6.2. Objectives 
1. To synthesise and characterise the next generation SSAs 20 – 24 (Figure 19) and 
explore their self-association properties in the gas phase using mass spectrometry 
(ESI-MS), the solution state using 1H NMR spectroscopy, tensiometry, zeta potential 
and rheometry, the solid state using single crystal XRD and in silico using low level 
computational modelling methods.45,94  
2. To establish whether 20 – 24 (Figure 19) could also act as supramolecular hydrogels. 
3. To explore the possibility that 20 – 24 (Figure 19) could act as antimicrobial agents 









2. Self-association results and discussion 
The self-association process of SSAs is complex and can be observed in the solid state, 
solution state and gas phase. Due to the complexity of the associations, a range of methods 
is needed to characterise these compounds. The process is presented as a flow chart as 
shown in Figure 20. 
 
Figure 20 – The techniques used in SSA characterisation. Blue squares represent an action, green 
squares represent a decision. 
In the solid state, single crystal X-ray diffraction is used to detect self-association (see 
section 2.1.). In the gas phase, dimerization of SSAs using ESI-MS has been observed, however 
this technique is used primarily as a characterisation technique (see section 2.1.2.).83 A range 
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of different experiments are used in the solution state to detect the different association 
events. qNMR is used to detect the presence of larger self-associated aggregates that cannot 
be observed by NMR, this is calculated as a percentage “loss”. This percentage “loss” is an 
apparent loss, as the compound cannot disappear, but becomes NMR silent as the individual 
molecular units self-associate, causing the resultant structure to adopt solid-like properties 
which can no longer be observed using standard solution state 1H NMR spectroscopy. The 
proportion of “loss” of a molecular component can be determined (see section 2.3.1.). 
If there is no “loss” of compound, 1H NMR self-association studies are used to 
calculate association constants and DOSY is used to calculate the size of the aggregates. If 
the aggregates are too large to be observed using solution state NMR (there is a “loss” of 
compound), then DLS is used to calculate the size of these aggregates, zeta potential to 
determine the stability, and tensiometry to ascertain the CMC and surfactant properties of 
the aggregates. 
2.1. Self-association in the solid state 
Single crystal XRD was first developed by Max von Laue in 1912, and further 
developed by Paul Knipping and Walter Friedrich.95 This led to these researchers receiving 
the Nobel Prize in Physics in 1914.96 Single crystal XRD is used regularly as an analytical 
technique within supramolecular chemistry and is a non-destructive technique used to 
obtain a three-dimensional structure of the repeating molecular unit within the single 
crystal.97 A single crystal is a material in which the crystal lattice structure is completely 
continuous, thus can act as a grating for the diffraction of X-rays.95 Single crystals of 22 and 
23 were obtained through slow evaporation of an EtOH:H2O 1:19 solution. Single crystals of 
24 were obtained through slow evaporation of EtOAc. Crystallography data was obtained and 
refined by Dr Jennifer Hiscock. 
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2.1.1. Single crystal XRD 
Dimerization between the urea and anion groups has previously been observed for 
many SSAs.83–90 Interestingly, only two hydrogen bonds formed between dimers of 22 (Figure 
21) with H2O molecules binding instead, compared to other SSAs, which form four.88 The 
crystal structure for 23 was also found to dimerize in the solid state, forming four hydrogen 
bonds between the urea and the sulfonate anion, but also binding to water (Figure 22). The 
single crystal X-ray structure of 24 has also been elucidated and shows two hydrogen bonds 
between the dimers (Figure 23). 
 
Figure 21 - Single crystal X-ray structure of 22, exhibiting a hydrogen bonded dimer, TBA counter 




Figure 22 – Single crystal X-ray structure of 23, exhibiting a hydrogen bonded dimer. TBA counter 
cation omitted for clarity. 
 
Figure 23 – Single crystal X-ray structure of 24, TBA counter cation omitted for clarity. 
The difference in hydrogen bond number in similar molecules has been previously 
seen in 26 compared to 19. Compound 19 forms four hydrogen bonds and can form hydrogels 
in 0.505 M salt solutions (as discussed in Section 3.), but 26 only forms two hydrogen bonds 
and cannot form hydrogels due to the formation of a competing intramolecular hydrogen 
bond.90 This hydrogen bond forms between the benzothiazole nitrogen and the urea NH, 
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which means that there is only one free NH free to take part in any molecular self-association 
events.90 
 
Figure 24 – Compound 26, previously reported by White et al. that shows only two hydrogen bonds 
as a dimer in the solid state.85 
2.2. Self-association in the gas phase 
Mass spectrometry (MS) is an analytical technique used to separate 
compounds/molecules by their mass and electrical charge, plotted as m/z ratio.98 MS can be 
used to identify unknown compounds by calculating the molecular weight, quantify known 
compounds with the use of an internal or external standard, and can also be used to identify 
the structure and chemical properties of molecules.99 MS requires the components to have 
an electrical charge, therefore, ionisation must occur.100 ESI is an ionisation technique often 
used to analyse fragile polar molecules as this method is a “softer” ionisation technique.100–
102 The compounds/molecules in solution are sprayed into a strong electric field which causes 
the sample solution to disperse into charged droplets. The droplets start to evaporate, 
increasing the charge density on the surface of the droplet. Finally, the droplets either 
become so charged that ions are repelled, or the droplet explodes, releasing the ions into the 
vacuum chamber.103 Other ionisation methods bombard the gaseous samples with an 
electron beam to knock off electrons from the sample to form positive ions, but this often 
leads to multiple charges within the sample and causes significant fragmentation.103 In this 
project, ESI-MS is not only used to fully characterise the compounds, but also shows the 
presence of dimers of the anionic component.83,85–90 It was shown in 1994 that non-covalent 
interactions, including hydrogen bonds, can be observed in the gas phase, allowing further 
characterisation of larger complexes.104 
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Molecular self-association in the gas phase has been previously reported for the 
anionic component of SSAs.83–90 Self-association and binding to other compounds has also 
been reported in perylene diimide ligands by Carolyn Mazzitelli et al. (27, Figure 25) where 
different perylene diimide ligands are used to bind to single stranded guanine-rich (G-
quadruplex) regions of DNA that fold into stable four stranded structures.105,106 The group 
used ESI-MS as a tool to distinguish between non-selective and selective binding, to 
characterise binding stoichiometry and to determine the binding modes between the ligands 
and the G-quadruplex DNA.105 Similar to Zhang et al., the researchers discovered that the 
self-association and binding modes are facilitated through π-π stacking around the G-
quadruplex DNA.71,105 
 
Figure 25 – Perylene diimide synthesised by Mazzitelli et al. that shows binding to DNA in ESI-MS.105 
The anionic component [M] of compounds 20 - 24 were analysed using ESI-MS to 
determine if self-association is present in the gas phase. Each compound was run at a 
concentration of ~ 1x 10-6 mol in MeOH. ESI-MS data was obtained and refined by Rebecca 
Ellaby. Compounds were found to be no exception to the general observation that the 
anionic component of SSAs 20 – 24 exists in both the monomeric [M] and dimeric [M + M + 




Table 1 – High resolution ESI- mass spectrometry. Theoretical and experimentally derived values. 
Compound 
m/z [M] m/z [M + M + H+] 
Theoretical Actual Theoretical Actual 
20 293.0602 293.0612 587.1274 587.1278 
21 307.0758 307.0769 615.1586 615.1585 
22 300.0118 300.0133 601.0306 601.0319 
23 390.0853 390.2425a 723.0550 723.3008 
24 200.0084 204.0132 409.0238 409.0301 
a – [M+C2H4] 23 contaminated with ethylene (28.0532). 
Using 20 as an example, the theoretical [M] m/z value was calculated to be 293.0602 
for the SSA anion, and a signal for this anion was observed at 293.0612 (Figure 26). The 
protonated dimeric species [M + M + H+] m/z was calculated to be 587.1274 (293.0602 x 2 + 
1.0072), and giving an actual value of 587.1278 (Figure 27). Dimeric species was also 
observed for the anionic component of 21, 22 and 23. Due to ethylene impurities being 
present within the spectrometer, the monomeric unit of 23 [M] was not found, it was instead 
observed as [M + C2H4].107 
As self-association occurs in the gas phase, it indicates that the non-covalent 
interactions that are formed between the dimers are relatively strong. The actual strength of 
these interactions cannot be determined in the gas phase, but these properties are explored 





Figure 26 – ESI-MS spectrum of 20 showing the monomeric species [M]. 
 
Figure 27 – ESI-MS spectrum of 20 showing the dimeric species [M + M + H+]. 
2.3. Self-association in the solution state 
The solid state and gas phase allow for the study of self-association without solvent. 
In the solution state however, solvent interactions must be considered. The binding modes 
of the SSAs depend on which solvent they are in, for example, in DMSO the SSAs 
predominantly form dimers, in EtOH:H2O 1:19 they form spherical aggregates and for some 
SSAs, in 0.505 M salt solutions they have been shown to form hydrogels,83–90 which is 
explained further in Section 3.1. The self-association patterns of the SSAs in different solvents 
are partially due to the hydrogen bonding nature of the solvents, but also the hydrophobic 
and hydrophilic affects driven by the solvent systems. DMSO and water interact with the SSAs 
due to their HBD and HBA groups, but as they have different numbers of HBA/HBDs, the 
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solvents interact with the SSAs in various ways.108,109 A range of different studies have been 
used to characterise the self-association of the SSAs. 
2.3.1. qNMR studies 
The application of qNMR to quantify the concentration of different molecular 
components that are visible to solution state NMR against an internal standard has been 
developed by the Hiscock group.86,110 This experiment exploits one of the properties of NMR: 
the integration of the peak is proportional to the number of nuclei responsible for the 
signal.111 For this experiment, the T1, the relaxation time, or the spin-lattice relaxation time, 
is increased to 60 seconds to ensure that the entire signal for all nuclei are collected, 
maintaining the accuracy of the experiment as different environmental conditions change 
the relaxation time. The limitations of 400 mHz NMR spectroscopy are to do with abundance 
of specific isotopes. NMR is less sensitive than MS, the natural abundance of the isotope 
needed must be considered, for example using C13 NMR, the relative abundance of C13 is low, 
so the sample must be more concentrated. Using solution NMR, all samples must be 
dissolved in deuterated solvent.112 
Hiscock et al. use qNMR to determine if the SSAs form aggregates that have solid like 
properties, which therefore cannot be observed using solution state NMR. Two solvent 
systems were incorporated within the scope of this study, DMSO doped with 1 % DCM and 
D2O doped with 5 % EtOH. DCM and EtOH are used as internal standards as these solvents 
are miscible within the bulk solvent of choice and the doped peaks appear away from the 
compound signals. The signal of the doped solvent is then comparatively integrated against 
the signal of both the anionic and cationic component of the SSA. 
To work out percentage “loss” of the anionic component, using 23 in DMSO-d6 as an 
example (Figure 28), the ratio of DCM to 23 is calculated (Equation 1). Therefore, the DCM 
peak at 5.75 ppm integrates for 2.88. The CH2 peak at 4 ppm should integrate for 2, but it 
integrates for 1.55 (Figure 28). To work out the percentage “loss” of signal, the actual value 
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is taken away from the expected (2 – 1.55 = 0.45), and then this value is divided by the 
expected (0.45/2 = 0.23), therefore, percentage loss (0.23 x 100 = 23 %) shows a 23 % “loss” 
of signal. This same calculation, but with EtOH as the dopant is carried out in D2O (Figure 29). 
Equation 1 – In DMSO-d6, millimoles of 20 calculated (0.0556 mM), the ratio of DCM (0.08 mM) to 20 
(0.0556 mM in 0.5 mL) is 1.44 per proton, but as DCM has two protons, the peak at 5.75 ppm 
integrates for 2.88. 
 
In DMSO-d6 there is no apparent percentage “loss” of signal for the anionic or cationic 
components of compounds 20 – 22 which indicates no large aggregates are formed that 
become invisible via conventional solution state NMR techniques, as shown in Table 2. 
Compound 23, unusually, shows a 22 % “loss” of signal of the anionic component, and 20 % 
“loss” of the cationic component in DMSO-d6, which has only occasionally been observed 
within this class of compound.87 This “loss” in DMSO-d6 could be due to the increased 
hydrophobicity of 23 due to the additional benzene ring. Rabah Khalil and Fadya Saadoon 
looked at the effect of adding benzene rings to the surfactant molecule sodium dodecyl 
sulfate (SDS) to form sodium dodecylbenzenesulfonate (SDBS).113 The researchers discovered 
that the added benzene ring caused the surfactants to form one-dimensional aggregations, 
whereas SDS formed wormlike micelles when added to varying concentrations of 
cetyltrimethylammonium bromide in the same aqueous conditions.113 The one-dimensional 
aggregates would enable π-π stacking between the anionic components of 23, potentially 
causing the formation of the larger aggregates which become NMR silent. Although 19 has a 
similar structure, it did not show a percentage “loss” in DMSO-d6, which could be due to the 
presence of the methyl group which provides steric hinderance, preventing effective 
stacking. 
In D2O, all the SSAs showed a “loss” of both anionic and cationic component signal, 
20 showing 31 and a 32 % “loss”, 21 44 and 39 %, 22 62 and 0.1 % (although this data must 
be treated with caution as the TBA signal integrated under the EtOH signal), and 23 showing 
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55 and 51 % of the anionic and cationic components respectively, as shown in Table 2. Due 
to the “loss” of signal of the compound, the extended structures of the SSAs cannot be 
observed or studied further using this solvent with solution state NMR spectroscopy. 
The “loss” of signal of the SSA is attributed to the larger aggregates having solid-like 
characteristics, meaning in solution they become NMR silent. As 20 – 22 did not show a “loss” 
of signal in DMSO-d6, all of the compound can be observed using solution state NMR, allowing 
determination of self-association constants and the sizes of the aggregates found. As 23 
showed a “loss” of signal in DMSO-d6, these experiments cannot be carried out. In D2O, as all 
the compounds showed a “loss” of signal, different studies must be carried out to determine 
the size and stability of these aggregates. All qNMR spectra can be found in the appendix 
(Figure S16 – S23). 
 
Figure 28 - 1H NMR spectrum (d1 = 60 s) of compound 23 (112 mM) in DMSO-d6/1.0 % DCM. 
Comparative integration indicates 22 % of the anionic component and 20 % of the cationic 
component of 23 has become NMR silent. 
 
Figure 29 - 1H NMR spectrum (d1 = 60 s) of compound 23 (5.56 mM) in D2O/5.0 % EtOH. Comparative 
integration indicates 55 % of the anionic component and 51 % of the cationic component of 23 has 
become NMR silent. 
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Table 2 – Overview of results of qNMR studies. Values given in % represent the observed proportion 
of the anionic component of the compound that has become NMR silent. SSAs were at 
concentrations of 111.12 mM in DMSO-d6, and 5.56 mM in D2O for all compounds except 22 which 
was carried out at 0.56 mM due to solubility issues. 
Compound 









20 0 0 31 32 
21 0 0 44 39 
22 0 0 62 0.1a 
23 22 20 55 51 
a -Signal integrated under the EtOH signal so data must be treated with 
caution. 
Interestingly, 22 shows a high “loss” of signal in D2O, 62 %. This high “loss” of signal 
of compound could be due to the benzothiazole unit. Alma García-Ortiz et al. looked into the 
nature of the self-assembly of benzothiazole derivatives and found that non-covalent bonds 
were forming between oxygen and sulfur (28, Figure 30).114 This interaction between S-O 
could potentially occur between dimers of 22, between the urea and the free sulfur on the 
benzothiazole unit. García-Ortiz et al. also discussed the planarity of the benzothiazole unit 
and how it enables π–π stacking.114 Although 23 also contains the benzothiazole unit, it is 
attached to a benzene ring, making the sulfur much less accessible to interact with the other 
molecules of 23. The added benzene ring also adds rotational movement into the structure, 
reducing its planarity. Peizhi Guo and Minghua Liu also looked at the self-association 
properties of the benzothiazole unit.115 The researchers swapped a benzimidazole unit (29, 
Figure 30) for a benzothiazole unit (30, Figure 30) and discovered that the two compounds 




Figure 30 – Garcia -Ortiz et al. used 28 to analyse the weak interactions resulting in self-assembly.114 
Guo and Liu used 29 and 30 to illustrate the importance of steric hindrance in self-assembly.115 
2.3.2. 1H NMR self-association studies 
As shown in Figure 20, if there is no observable “loss” of signal in qNMR, the next 
step is to determine self-association constants. NMR has the ability to monitor weak and 
non-covalent interactions,116 for example, hydrogen bonds can be observed as the shift in 
ppm of 1H signals (up to 5 ppm)117–119 and π-π interactions through 1H chemical shifts of CHs 
in quinacridone derivatives.120 
To directly monitor the hydrogen bonds that form between the HBD urea NHs and 
the HBA’s on the SSAs, a series of 1H NMR dilution studies were performed. Binding 
constants were also calculated by fitting data to binding isotherms using Bindfit.121 The 
isotherms used in this study, the Equal K (EK) and Co-operative equal K (CoEK) have 
limitations: both assume one component, one-dimensional homogenous aggregates.122 The 
CoEK model assumes the first association event has different energy than that of 
subsequent events and the EK model assumes all association events are constant.123 
Compounds 20 and 21 were synthesised to determine the importance of alkyl chain 
length in self-association (Figure 31a and b). Hiscock et al. observed that the ethyl linker 
causes the SSA to cyclise and form an intermolecular bond to form a six membered ring in 
the crystal structure,85 and it is hypothesised that 20 forms a similar ring structure (Figure 
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31a). The propyl linker (21) instead forms dimers (Figure 31b) which has previously been 
reported.86 
 
Figure 31 – The hypothesised self-association observed in 20 and 21. a) Compound 20 forms an 
intermolecular bond to form a six membered stable ring, b) compound 21 dimerizes which is 
characteristic of SSAs.83–90 
To quantify the strength of the hydrogen bonds that form in SSA self-association 
events, a series of 1H NMR dilution studies were performed. These studies were undertaken 
in a DMSO-d6 0.5 % H2O solution. Due to the hygroscopic nature of DMSO-d6, an aliquot of 
H2O was added to minimise changes in H2O concentration to ensure that the samples of the 
study were comparable. 
The results these of dilution studies show that as the concentration of the SSA 
increases, the NHs protons shift downfield. The change of chemical shift is due to the 
formation of the hydrogen bond. Kumar et al. proposed that the bigger the chemical shift, 
the greater the strength of the bond.118 For 20, there is a very small change in the chemical 





Figure 32 – Enlarged 1H NMR stack plot of compound 20 in a DMSO-d6 0.5 % H2O solution. Samples 
were prepared in series with an aliquot of the most concentrated solution undergoing serial dilution. 
 
Figure 33 - Graph illustrating the 1H NMR down-field change in chemical shift of urea NH resonances 
with increasing concentrations of compound 20 in DMSO-d6 0.5 % H2O solution (298 K). 
Due to both the small change in chemical shift (0.047 ppm for 20 compared to 
0.170 ppm for 21) and the linearity of the trend line points to the fact that there is no real 
self-association between the anionic components of the SSA, adding to the hypothesis that 
20 forms an intermolecular hydrogen bond to form a cyclic structure (Figure 31). The six 
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membered ring is more kinetically stable than a dimer, so increasing the concentration of 
20 has a smaller effect on dimer formation, as the cyclic structure is already formed. 
Comparing the change in chemical shift of 20 to 21, which has an almost identical structure, 
the change in ppm is almost four times greater (Figure 34). 
To quantify the strength of the hydrogen bonds that formed during the self-
association events, the changes in chemical shift were fitted to two binding isotherms; the 
dimerization EK and the CoEK (Table 3). The majority of SSAs form dimers in DMSO,83–90 but, 
as 20 has a negative Ke and Kdim value it shows that the data does not fit the isotherm. The 
data does not fit as there are technically two self-association events occurring; i) the 
cyclisation event with the intermolecular hydrogen bond, and ii) the dimerization event that 
usually occurs between the anionic component of the SSAs. As two self-association events 
are being fitted, technically the CoEK model fits better, as the Kdim values are higher than the 
EK values (CoEK – Kdim = 3.66 M-1, EK – Kdim = -4.13 x10-2 M-1). Although the errors are lower, 
the solution does not fit the one compound one directional binding event so the data cannot 
be fitted to either isotherm as there are more complex equilibria that are involved. 
Compound 21 shows a relatively small EK Kdim value of 1.21 M-1, but due to the high errors 
for the CoEK isotherm, (Kdim = ± 1.9 %, ρ = ± 11.2 %), it can be inferred that 21 forms dimers 
in DMSO-d6, which is supported by the DOSY data as shown in Section 2.3.3. 
Compound 22 also shows a relatively small change in ppm and little to no curvature 
of the graph (Figure 35), leading to negligible association constants (Kdim = 0.09 M-1). As 
seen in the solid state (Section 2.1.1), the anionic component of 22 only forms two 
hydrogen bonds compared to the usual four observed in anionic components of SSAs, 
similarly to 26. Interestingly, 26 also shows very small EK dimerization constants (Kdim = 0.6 
M-1) compared to 19 (Ke = 2.7 M-1) which forms four hydrogen bonded dimers between the 
anionic component in solid state.85 It could therefore be inferred that, due to the hydrogen 
bonding seen in the solid state in both the anionic components of 22 and 26, the hydrogen 
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bonds that form in the solution state are weak also, as observed in the low association 
constants compared to 19 that forms both four hydrogen bonds and has a high association 
constant (Ke = 2.7 M-1). Due to peak overlap, the position of the NHs could not be 
determined for 0.093 M and 0.080 M. All 1H NMR spectra and Bindfit links can be found in 
the appendix (Figure S24 – S32). 
 
Figure 34 - Graph illustrating the 1H NMR down-field change in chemical shift of urea NH resonances 
with increasing concentrations of compound 21 in DMSO-d6 0.5 % H2O solution (298 K). 
 
Figure 35 - Graph illustrating the 1H NMR down-field change in chemical shift of urea NH resonances 
with increasing concentrations of compound 22 in DMSO-d6 0.5 % H2O solution (298 K).  
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Table 3 – Self-association constants (M-1) calculated for 20 – 22 in DMSO-d6 0.5% H2O solution at 298 
















20 -0.08 (± 0.9 %) -4.13 x 10
-2 
(± 0.4 %) 7.32 (± 2.6 %) 3.66 (± 1.3 %) 0.26 (± 6.2 %) 
21 2.43 (± 2.0 %) 1.21 (± 1.0 %) 13.2 (± 3.9 %) 6.60 (± 1.9 %)  0.32 (± 11.2 %) 
22 0.18 (± 3.8 %) 0.09 (± 1.9 %) -0.68 (± 17.3 %) -0.34 (± 8.6 %)  -212.19 (± 14.9 %) 
23 a a a a a 
a – Data could not be fitted as a “loss” of the anionic component of the compound was observed in 
DMSO-d6. 
2.3.3. 1H NMR DOSY studies 
NMR DOSY is a technique that separates NMR signals according to the diffusion 
coefficient of each molecule and allows mixtures of compounds to be analysed, and is the 
next step shown in Figure 20.124,125 The diffusion coefficient can be converted into the 
hydrodynamic diameter using the Stokes-Einstein equation (Equation 2).126 
Equation 2 – The Stokes-Einstein equation which is used to calculate the hydrodynamic diameter 
using the diffusion coefficient. 
 
The major limitation of DOSY is the Stokes-Einstein equation which assumes the 
molecule is spherical, when often this is not true (Figure 36). Due to this limitation, the 





Figure 36 – Limitations of using the Stokes-Einstein equation: a) large molecule with tails, but the dH 
includes the tails of, b) non-spherical molecule, but the dH assumes it is spherical, c) multiple 
molecules, but the dH is assumed to be the collective size. 
To calculate the hydrodynamic diameter of the anionic and cationic components, 
using the cationic component of 20 as an example (Figure 37), the diffusion constant (D) is 
averaged (1.71 x 10-10 m2/s) and then substituted into the Stokes-Einstein equation (Equation 
3), to get a value of 1.28 nm as shown in Table 4. 
Equation 3 – Calculation of dH using the cationic component of 20 as an example. 
 
 
Table 4 – Overview of hydrodynamic diameters (nm) for 20 – 21 in DMSO-d6 at 298 K. 
Compound 
Hydrodynamic diameter (nm) 
Anion Cation 
20 1.28 1.22 
21 1.37 1.22 
22 1.29 1.20 
23 a a 
a – Study not completed due to signal “loss” in DMSO-d6. 
 
The 1H NMR DOSY of 20 - 22 in DMSO-d6 showed that the anionic and cationic 
components of the compounds diffuse at different rates, so therefore have different 
hydrodynamic diameters, as shown in Table 4. As the anion and cation have different 
diffusion constants, it shows that TBA does not co-ordinate strongly with the anionic SSA 
component in DMSO-d6. The anionic component of 20 – 22 have hydrodynamic diameters of 
1.28, 1.37 and 1.20 nm respectively, which represent low order complex formation, such as 
monomers, dimers or trimers. The cation for 20 – 22 is TBA, and, as the measured 
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hydrodynamic diameter in each compound is within ± 0.02 % (1.20 nm – 1.22 nm) it indicates 
the validity of these data. All 1H NMR DOSY spectra can be viewed in the appendix (Figure 






Figure 37 - 1H DOSY NMR spectrum of the compound 20 (55.56 mM) in DMSO-d6 at 298 K. The anionic 
component is highlighted in red and the cationic component in blue. A table showing diffusion 
constants for each peak used to calculate the hydrodynamic diameter. Anionic component of 20 (dH = 
1.28 nm). Peaks 1 - 7 and 9 correspond to the anionic component of 20 while peaks 8, 10 - 12 
correspond to the cationic component of 20. 
2.3.4. Tensiometry studies and Critical Micelle Concentration (CMC) 
determination 
The CMC is the concentration at which surface tension does not continue to decrease 
with increasing concentration of a compound with surfactant properties.127 The CMC is 
determined to be the concentration above which any extra addition of compound will form 
larger self-associated structures within the bulk of the solution (micelles, reverse micelles, 
vesicles, aggregations) as shown in Figure 38.128,129 Figure 38 illustrates CMC determination, 
but, although this process is shown as micelles/spherical aggregates, there are hypothesised 
to be many types of structures present. One of the limitations of CMC determination is that 
aggregates may be present before CMC is reached as the larger structures are in dynamic 
equilibrium with the surface structures as the surface is not yet saturated.130 Another 
limitation of this experiment is that not only micelles are formed. It is hypothesised that the 
aggregates SSAs form are multilamellar. The CMC for 21 and 23 were determined using a 




Figure 38 – The initial determination of CMC by Williams et al..129 
The CMC and the surface tension at the CMC for 21 (Figure 39) and 23 were 
calculated (Table 5). The CMC is determined by using simultaneous equations of the lines to 
find the point where they intercept.  
 
Figure 39 - Calculation of CMC (32.12 mM) for compound 21 in an EtOH:H2O 1:19 mixture using 





Table 5 –Summary of CMC and surface tension at CMC. Data obtained in an EtOH:H2O 1:19 solution. 
Compound CMC (mM) Surface tension at CMC (mN/M) 
20 a a 
21 32.12 44.88 
22 a a 
23 5.16 66.97 
a – Could not be calculated due to compound solubility. 
The difference in CMC between 21 (32.12 mM) and 23 (5.16 mM) is over 6 times. The 
difference in CMC is most likely due to the difference in hydrophobicity of the compound: 23 
is more hydrophobic as the anionic component has a larger conjugated ring system. Anoune 
et al. completed a study of 49 surfactants and discovered that increasing the hydrophobicity 
of the compound causes a decrease in CMC, as seen with compounds 21 and 23.131 The lower 
the CMC, the greater the surfactant properties of the compound, increasing the ability of the 
compounds to lower the surface tension of the water. Therefore, 23 is a more effective 
surfactant than 21 as less compound is needed to saturate the interface. All CMC graphs can 
be found in the appendix (Figure S39 – S40). 
2.3.5. Dynamic Light Scattering Studies 
As shown in Figure 20, if there is a “loss” of compound in the qNMR experiment, the 
larger aggregates must be studied outside of NMR spectroscopy as they are outside the scope 
of the machine. DLS is a non-destructive method often used for characterisation of 
nanoparticles.132,133 This method uses the scattering of light and the Brownian motion of the 
particles to calculate the size of the particles in solution.133 The size of the particle changes 
the intensity of the scattered light (Figure 40) and, using the Stokes-Einstein equation 
(Equation 2), the hydrodynamic diameter can be calculated.134 The limits of the size 
calculation is 1 – 1000 nm,132 therefore, low ordered complexation will be visible, but the 
sizes cannot be calculated. As the Stokes-Einstein equation is used, there is an assumption 
that everything is spherical (Figure 36). The graphs that are produced are intensity 
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distributions, weighted by size, so the graphs cannot be treated as a comparative number of 
that size in the solution. As the refractive indexes of the compounds are unknown, the 
polydisperity (PDI) must be considered. A higher PDI (%) means the molecules/aggregates 
have a larger range of sizes.  
 
Figure 40 – The difference between Raleigh and Mie scattering. a) Raleigh scattering, not angle-
dependent, b) Mie scattering, angle dependent, c) Mie scattering, angle-dependence increases with 
particle size. 
Large aggregates that are invisible to the solution state 1H NMR were found for 
compounds 20 - 22 in EtOH:H2O 1:19, evidence of these first obtained through qNMR studies 
(Section 2.3.1.). The compounds exhibit a range of different sizes as shown in Table 6 and PDI 
of 16 – 36 %. The lower PDI shows that the aggregates are of a similar size, therefore have a 
higher uniformity. 
All the compounds have a PDI of ~25 – 30 % at both 0.56 mM and 5.56 mM, except 
23. Compound 23 has a PDI of only 16 % at 0.56, and 27 % at 5.56 mM. It is proposed that as 
the DLS was carried out below the CMC for 23, less larger aggregations form as the interface 
is not yet saturated. This hypothesis is corroborated by the difference in peak maxima of 23: 
255 nm at 5.56 mM and 155 nm at 0.56 mM. Additionally, there is a 40 % decrease in peak 
maxima for 23, whereas the biggest difference in peak maxima observed in the compounds 
other than 23 is observed in 20, where a 20 % decrease in peak maxima is observed (200 nm 
at 5.56 mM and 156 nm at 0.56 mM). 
As there was a “loss” of signal in the qNMR of 23 in DMSO-d6, the extended 
aggregates were characterised by DLS in DMSO. Compound 23 shows an increased 
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polydisperity, 36 % compared to 15 – 25 %, thus there are hypothesised to be lots of different 
macrostructures present.84 Due to the many macrostructures, indicated by the increased 
polydisperity, there is a much higher error on the peak maxima. The peak maxima for 23 in 
DMSO also is much higher, at 1381 nm, compared to the other compounds in EtOH:H2O 1:19, 
156 – 255 nm, an order of magnitude in difference, as within solutions of 23 in DMSO, many 
different structures are present, so these structures “clump” together to form even larger 
aggregates.83–90 All DSL data can be found in the appendix (Figure S41Error! Reference source 
not found. – S56). 
Table 6 – Average intensity particle size distribution for 20 - 23, calculated from 10 DLS runs in 
EtOH:H2O 1:19. Samples were prepared in series, with an aliquot of the most concentrated solution 
undergoing serial dilution and measured after heating to 40 °C and cooling to 25 °C. Error = standard 
error of the mean and given to 1 dp. 
Compound Concentration (mM) Peak maxima (nm) Polydisperity (%) 
20 5.56 199.94 (± 3.1 %) 26.05 (± 0.3 %) 
 0.56 156.33 (± 1.8 %) 24.74 (± 0.5 %) 
21 5.56 153.86 (± 1.1 %) 24.67 (± 0.1 %) 
 0.56 142.49 (± 1.8 %) 24.81 (± 0.2 %) 
22 0.56 180.95 (± 2.5 %) 25.93 (± 0.2 %) 
23 5.56 255.42 (± 7.1 %) 27.37 (± 0.2 %) 
 0.56 155.46 (± 2.4 %) 15.96 (± 0.3 %) 
 
Table 7 - Average intensity particle size distribution for 20 - 23, calculated from 10 DLS runs in DMSO. 
Samples were prepared in series, with an aliquot of the most concentrated solution undergoing 
serial dilution and measured after heating to 40 °C and cooling to 25 °C. Error = standard error of the 
mean and given to 1 dp. 
Compound Concentration (mM) Peak maxima (nm) PDI (%) 
20 a a a 
21 a a a 
22 a a a 
23 111.12 1380.55 (± 23.17) 35.74 (± 1.4 %) 
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a – Study not completed due to no signal “loss” in DMSO-d6. 
2.3.6. Zeta Potential 
Zeta potential, or “electrokinetic potential”, defines the potential of a colloid particle 
moving through an electrical field.134,135 Zeta potential is often used to define the stability of 
a colloid particle or aggregation. Values of ± 0 - 10 mV are unstable, ± 10 - 20 mV are 
moderately stable and ± 20 - 30 mV are stable.91,136 In reality, it is much more complicated. 
In the cell, liposomes, which are stable vesicles made from phospholipids, have a zeta 
potential of -10 - -40 mV.92 This data implies that zeta potential can act as a “ball park” figure 
of stability of aggregates, but context is important. For example, the solvent used must be 
taken into account, also whether the sample is in vivo, or ex vivo. The zeta potentials for 20 - 
23 were found in EtOH:H2O 1:19. 
Table 8 contains the zeta potential values for 20, 21 and 23, at 5.56 mM and for 22 
at 0.56 mM due to solubility issues. The zeta potentials for 20 and 21 are ± 20 - 10 mV, 
implying moderately stable aggregates. Although the aggregates are only considered to be 
“moderately stable” the DLS studies (Table 6) suggest that they are stable enough to be 
characterised. The zeta potentials for 22 and 23 are both ± 30 mV, so are “stable” aggregates. 
Both 22 and 23 contain the benzothiazole unit, which is thought to contribute towards the 
stability of the aggregates, previously suggested by García-Ortiz et al. (Figure 30).114 
Table 8 - Summary of zeta potential at 5.56 mM for 20, 21 and 23 and 0.56 mM for 22 due to 
solubility issues. 





This increased stability of 22 could also explain the higher percentage “loss” of signal 




2.4. Low level in silico modelling 
Computational modelling is used to model then predict the properties and 3D 
conformation of compounds and are able to predict hydrogen-bonding and the geometry of 
the bonds that are formed. One of the ways computational chemistry can support organic 
chemistry by predicting electrostatic potential maps. These potential maps visualize the 
electropositive and electronegative areas of a compound to see whether molecular 
interactions will form.137 Electrostatic potential maps for the anionic component of 20 - 23 
were calculated using Spartan 16” with energy minimised, semi-empirical PM6 modelling 
methods to derive comparative Emax and Emin surface values.138 The in silico data was obtained 
and refined by Rebecca Ellaby. 
The Emax is the most negative point on the surface of the molecule, and the Emin the 
most positive. LogP value is used as a comparative measure of lipophobicity, the higher the 
logP value, the more hydrophobic the compound. The Emax, Emin, and LogP values for 20 – 23 
can be found in Table 9. The Emin of the compound is expected to be at the sulfonate and/or 
the urea oxygen of the compound, the most likely HBA groups. The Emax of the compound is, 
for 20 and 21, the naphthalene as this part of the compound is most electron rich due to the 
π electrons that delocalise over the aromatic rings. Due to the missing alkyl group between 
the sulfonate and urea in 20, it has a much lower Emin value of -88 KJ mol-1 (Figure 41), 
compared to 20, 12 kJ mol-1Error! Reference source not found.. All in silico data can be found 
in the appendix (Figure S64 – S67). 
Table 9 – Emax, Emin, and LogP values for 20 - 23. 
Compound Emax (kJ mol-1) Emin (kJ mol-1) LogP 
20 -721.417 -88.0876 1.05 
21 -768.478 12.0290 1.51 
22 -717.433 -48.5147 0.86 




Figure 41 - Electrostatic potential map calculated for 20. Emax  and Emin values depicted in the figure 






A gel is composed of a liquid (solvent) which is encapsulated by the second 
component, the gelator. According to Estroff et al. the liquid component takes up ~99 % of 
the gel by weight, with the gelator only accountable for 1 %.139 The classification of gels can 
be broken down, as shown in Figure 42, as the general term “gel” is quite broad – gels are 
solid-like and have viscolastic properties.140 A “gel” can be classified by the origin of the 
material, the constituents that make up the gel, the type of crosslinking, and also the media 
they encapsulate.141 
 
Figure 42 – Flow chart of the classification of different gel systems. 
Brezinger discovered the first low molecular weight (LMW) hydrogelator, 30 (Figure 
43) in 1892.142 However, the properties of the gel were not studied until 1921, by Gortner 
and Hoffman.143 Gortner and Hoffman discovered that the gel could withstand an inversion 
test in ~5 % EtOH ~95 % H2O, at 0.1 % concentration by weight.143 The characteristics of the 
gel were studied in 1978 by Menger et al. using NMR studies and X-ray crystallography.144 
These researchers went on to modify the structure of 30, decreasing the minimum gelation 
concentration (MGC) to 0.01 % by weight by increasing the electron-withdawing properties 




Figure 43 – The first reported LMW gelator, 30142 and the modifications made by Menger et al., 31.145 
Supramolecular gels form through self-assembly via non-covalent interactions, 
unlike polymeric gels which are based on covalently cross-linked networks of polymers.146,147 
These non-covalent interactions occur between monomeric units of LMW gelators.148 These 
gels are broadly classified into two categories based on the solvent that has been immobilised 
within the 3D gel matrix; organogels, which trap organic solvent,140,149,150 and hydrogels, 
which trap water.38,139,146,151–153 Another difference between the two classes of gels is how 
the gelation is driven, initially discovered by Miravet et al.; organogels are enthalpy driven 
and hydrogels are entropy driven.154–158 The chemical driving force of gelation can range from 
weak intermolecular interactions to chemical covalent bonds.159 Any and all non-covalent 
interactions play a part in acting as the driving force of gelation, from van der Waals 
interactions, to hydrogen bonds, π-π interactions to ionic bonds, but solvent interactions, 
including the solvophobic effect are incredibly important.160 The solvophobic effect is the 
tendency of dissolved molecules to cluster as the interactions between the solvent particles 
and the molecules increase.161 
Hydrogen bonding is one of the most used non-covalent interactions in the 
construction of supramolecular gels.159 As explained in Section 1.4, the urea motif is often 
used to facilitate hydrogen bonding. Pyridyl based ureas have been extensively studied by 
Steed et al..162,163 These researchers have also explored the ability of these compounds to 
form supramolecular gels.164 Pandurangan et al. used the urea functional group to synthesise 
a family of compounds that form supramolecular gels in various solvents (THF:H2O with or 
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without the addition of AgNO3).165 The general structure of these hydrogelators are shown in 
Figure 44, 32 - 35.165 The researchers deduced that, in the solid state (single crystal XRD) 
hydrogen bonded dimers and the effect of face-to-face and edge-to-face π-π stacking helped 
give rise to the supramolecular network.165 As these interactions were discovered in the solid 
state, it can be hypothesised that similar structures could be present within the solid state 
gel fibres. 
 
Figure 44 -  Chemical structure of pyridyl ureas.165 
Hiscock et al. discovered that 19 formed a hydrogel in 15 different 0.505 M salt 
solutions.90 The properties of these hydrogels were initially characterised using rheology, and 
then further analysed these gels using a plate reader.166 As the main aim of this project was 
to produce potential topical antimicrobial hand gels, the pH of the gel must be between 4 
and 7, the range of human skin.167 NaCl, KCl, NaNO3, NaH2PO4, NaOBz and Na2SO4 salts and 
gels all fell within this range, and enabled observation of how the geometries of the salts 
effected the gelation of the novel compound 23. In this set of salts the changes include: the 
cation (Na+ to K+); the effect of different geometries of the anion; trigonal (NaNO3); 
tetrahedral (NaH2PO4); the effect of increasing the hydrophobicity of the salt (NaOBz); and 
the number of cations and thus the basicity of the salt (Na2SO4). 
3.2 Rheology results and discussion 
3.2.1. Minimum gelation concentration 
The MGC of a compound is the minimum amount of gelator (mass) required to gelate 
a standard volume of liquid, in this case 1 mL of an aqueous salt solution. To find the MGC of 
23 in the different salt solutions the vial inversion test was conducted at a temperature of 25 
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C. Table 10 gives an overview of the MGCs of the hydrogels produced from the six salt 
solutions explored in this project. The samples were heated to ~ 50 °C and left to cool on the 
benchtop. 




NaCl 1.5 1.5 
KCl a 2.5 
NaNO3 1 1.5 
NaH2PO4 b 1.5 
NaOBz 2 1.5 
Na2SO4 b 3.5 
a – Partial gel formed at 5 mg/mL. 
b – Precipitation occurred at 5 mg/mL. 
The structures of 19 and 23 are almost identical, differing only by the presence of a 
methyl group on the benzothiazole found in 19. It is hypothesised that the reduction in 
hydrophobicity and steric effects caused by the removal of the methyl group has resulted in 
changes in the physical properties of the gels of 23 compared to 19.90 
3.2.2. Amplitude sweep 
Rheological methods can be used to characterise the viscoelastic behaviour and 
properties of gels.159,168 Gels can be characterised by the way that the materials react to 
oscillatory stress, based on the behaviour of flow and deformation.146 In the graphs 
produced, storage modulus (G’) refers to the elastic component and the materials ability to 
store energy, and loss modulus (G’’) refers to the materials ability to dissipate energy, which 
relates to the liquid component. The viscoelastic properties of hydrogels formed of 5 mg/mL 
of 23 in various salt solutions were studied. At 5 mg/mL gel fibres can form (as discussed in 
Section 3.2.7), allowing the formation of the gel network. Salt solutions where 5 mg/mL of 
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23 did not pass the inversion test (NaH2PO4 and Na2SO4) so cannot be considered gels and 
were not therefore characterised using rheology. 
An amplitude sweep is used to determine how robust the material is and also 
determines the samples linear viscoelastic region (LVR), the area where deformation of the 
sample is non-destructive. Amplitude sweeps for 23 (5 mg/mL) in NaCl (Figure 45), NaNO3 
(Figure 46) and NaOBz (Figure 47) were carried out. 
 
Figure 45 - Graph showing average results (n=3) from amplitude sweep experiments used to define 
the linear viscoelastic region of the sample at 298 K. Compound 23 (5 mg) in 1 mL of aqueous NaCl 




Figure 46 - Graph showing average results (n=3) from amplitude sweep experiments used to define 
the linear viscoelastic region of the sample at 298 K. Compound 23 (5 mg) in 1 mL of aqueous NaNO3 
solution (0.505 M) (1 = 100 %). 
 
Figure 47 - Graph showing average results (n=3) from amplitude sweep experiments used to define 
the linear viscoelastic region of the sample at 298 K. Compound 23 (5 mg) in 1 mL of aqueous NaOBz 
solution (0.505 M) (1 = 100 %). 
Interestingly, hydrogels of 23 in NaNO3 and NaOBz do not exhibit a cross over point. 
The lack of crossover point could be due to these gels having stress responsive behaviour as 
the G’ does not decrease, implying that the elastic behaviour of these gels is maintained at 




3.2.3. The best way to conduct experiments 
To ensure the whole of the sample was studied in its entirety, a solution of 19 was 
heated and allowed to set with the spindle geometry (in this case a Krebs spindle, a rotating 
paddle that sits inside a vial) submerged, allowing the hydrogel to form around the vanes.90 
Submerging the geometry prior to gel formation reduces the likelihood of disruption to the 
gel.90 For 23, whilst conducting frequency sweeps across the range of salts, it became 
apparent that for the hydrogels that contained NaNO3 and NaOBz, occasionally a gel would 
not form. Instead, 23 would precipitate out of solution. An experiment was devised using the 
NaCl hydrogel, where the heated solution was allowed to gel around the geometry and the 
frequency sweep conducted. A separate experiment where the geometry was plunged into 
the already formed hydrogel then the frequency sweep was also performed. It is 
hypothesised that the geometry of the rheometer disturbs the gel fibres that form, disrupting 
the gel network. Figure 48 shows the frequency sweep from the gel forming around the 
geometry whilst Figure 49 shows the frequency sweep of the gel formed before inserting the 
geometry. 
 
Figure 48 - Graph showing average results (n=3) from frequency sweep experiments obtained from 
the linear viscoelastic region under a constant shear strain (γ) of 0.0277 % (298 K). Solution heated 
and gel formed around geometry. Compound 23 (5 mg) in 1 mL of aqueous NaCl solution (0.505 M) 




Figure 49 - Graph showing average results (n=3) from frequency sweep experiments obtained from 
the linear viscoelastic region under a constant shear strain (γ) of 0.0277 % (298 K). Solution heated 
and gel formed before inserting geometry. Compound 23 (5 mg) in 1 mL of aqueous NaCl solution 
(0.505 M) (1 = 100 %). 
The results of this experiment showed that the frequency sweep of the pre-formed 
gel (Figure 49) had smaller errors than when the gel formed around the geometry (Figure 
48). This data shows that the geometry can be inserted in either the hot solution or a pre-
formed gel and the results are comparable. 
3.2.4. Frequency sweep 
Previously, for 19, the frequency sweep was carried out at a standard % strain across 
all the salt solutions that were tested.90 However, as 23 formed substantially different gels in 
each of the different salts, one LVR could not be found for all hydrogels. Instead, the LVR was 
calculated for each gel individually. Figure 50 shows the angular frequency sweep of 23 (5 
mg/mL) in 1 mL of aqueous NaCl (0.505 M) solution and was found to exhibit similar 
behaviour to 19 in the same conditions: the G’ is stable, then increases.90 The two other salts 
tested, NaNO3 (Figure 51) and NaOBz (Figure 52) show very different behaviour to 19 in the 
same conditions. G’ varies to a higher degree in the hydrogel of NaNO3 (10 - >100 Pa for 23 
compared to 19 with variation of 80 – 100 Pa).90 For the frequency sweep carried out for 
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NaOBz (Figure 52), the errors are both very large and also cross over, indicating that this gel 
falls on the boundary of what is a ‘gel’. 
 
Figure 50 - Graph showing average results (n=3) from frequency sweep experiments obtained from 
the linear viscoelastic region under a constant shear strain (γ) of 0.0277 % (298 K). Compound 23 (5 
mg) in 1 mL of aqueous NaCl solution (0.505 M). 
 
Figure 51 - Graph showing average results (n=3) from frequency sweep experiments obtained from 
the linear viscoelastic region under a constant shear strain (γ) of 0.0195 % (298 K). Compound 23 (5 




Figure 52 - Graph showing average results (n=3) from frequency sweep experiments obtained from 
the linear viscoelastic region under a constant shear strain (γ) of 0.0720 % (298 K). Compound 23 (5 
mg) in 1 mL of aqueous NaOBz solution (0.505 M). 
3.2.5. Test of oscillatory stress 
Due to the lack of cross over point observed in the NaNO3 (Figure 46) and NaOBz 
(Figure 47) hydrogels, it was hypothesised that these gels could be strengthened by 
oscillatory stress. To test this hypothesis, an amplitude sweep was run on a sample, the LVR 
determined, and the frequency sweep carried out on the same sample. The amplitude 
sweeps of NaNO3 and NaOBz can be found in the appendix (Error! Reference source not 
found. and S88). The subsequent frequency sweep of NaNO3 (Figure 53) is very different to 
that of the frequency sweep on a complete hydrogel (Figure 51). Interestingly in Figure 53, 
the elastic component of the hydrogel, G’, changes only a small amount, implying that this 
stays constant, but the liquid component of the gel, G’’, has higher errors and also varies to 
a higher degree compared to the frequency sweep on the complete hydrogel. This would 





Figure 53 - Graph showing average results (n=3) from frequency sweep experiments obtained from 
the linear viscoelastic region under a constant shear strain (γ) of 0.0209 % (298 K), after running an 
amplitude sweep on the same sample. Compound 23 (5 mg) in 1 mL in aqueous NaNO3 solution (0.505 
M). 
The hydrogel of NaOBz (Figure 54) exhibits a similar trend, after an amplitude sweep 
the G’ stays relatively constant, although the error bars for both G’ and G’’ are much larger, 
often crossing over. Large error bars can also be seen in the frequency sweep of NaOBz on a 





Figure 54 - Graph showing average results (n=3) from frequency sweep experiments obtained from 
the linear viscoelastic region under a constant shear strain (γ) of 0.0174 % (298 K), after running an 
amplitude sweep on the same sample. Compound 23 (5 mg) in 1 mL of aqueous NaOBz solution (0.505 
M). 
3.2.6. Sonication test 
For NaNO3 and NaOBz it was hypothesised that the gels were being strengthened by 
stress, so this was investigated by sonicating a salt solution containing 23, taking images 
every 5 minute up to 30 minutes, and every 10 minutes up to an hour to see if gelation 
occurred. This test was to prove whether shear strain in the form of sonication would cause 
gelation, following observations from the amplitude sweep of NaNO3 and NaOBz to a certain 
extent (Figure 46 and Figure 47). This experiment was repeated n=3, but gelation did not 
occur after one hour of sonication. Although in the second test, the NaNO3 gel formed a gel-
like structure (held up under the inversion test but not homologous, Figure 55) that only 
broke down at 30 minutes (Figure 56). The data from this sonication experiment shows that 
heat is required to break down the self-associated structures formed initially (spherical 
aggregations as shown in Section 2.3.5). Pictures of gels can be found in the appendix (Figure 




Figure 55 - Sonication test at 0 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz inverted 
imaged under UV irradiation (test no. 2). 
 
Figure 56 - Sonication test at 25 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
inverted imaged under UV irradiation (test no. 2). 
3.2.7. Microscopy 
Due to the intrinsic fluorescent nature of both 22 and 23, fluorescence microscopy 
was used to help understand the nature of gel formation. Although 22 does not form gels, a 
sample in a NaCl (0.505 M) solution was imaged to potentially explain why this compound 
does not form hydrogels. The hydrogels of 23 in the various salt solutions were also viewed 
under the fluorescence microscope to observe the gel fibres. All microscopy data was 
obtained and refined by Nyasha Allen. 
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Figure 57 is a transmitted LED image of 22 (5 mg/mL) in a 0.505 M NaCl solution. In 
Figure 57 only small circular aggregates can be observed, circled in orange, characteristic of 
SSAs, as explained in Section 2.3.5. 
 
Figure 57 - Transmitted LED microscopy image of compound 22 (5 mg/mL) in NaCl (0.505 M). 
The microscopy of 23 however, shows the gel fibres that form when the sample has 
been heated and then cooled. Figure 58a is a DAPI LED microscopy image of 23 (5 mg/mL) in 
0.505 M of aqueous NaCl, and the gel fibres can easily be seen as the long white lines running 
through the image. Interestingly, the way the fibres that form are salt dependent. The gel 
fibres in Figure 58a (NaCl) are relatively long and thin, with the bright spots hypothesised to 
be large aggregations of 23. Figure 58b (KCl), where the cation of the salt solution is the only 
difference, show a more conjugated network, were the fibres seem to curl around each 





Figure 58 - DAPI LED fluorescent microscopy image of 23 (5 mg/mL) in  a) NaCl, b) KCl, c) NaNO3, d) 
NaH2PO4, e) NaOBz, f) Na2SO4 at 0.505 M. Scale bar illustrates 5 μm. 
The gel fibres observed in Figure 58d (NaH2PO4) are much straighter compared to the 
hydrogels observed in NaCl and KCl (Figure 58a and b). Again, the only difference between 
the hydrogels is the salt solution. This difference in the gel fibres could explain why the 
hydrogel of NaH2PO4 could not be characterised using rheology as the material that formed 
could not withstand the inversion test at 5 mg/mL. The hydrogel containing NaOBz as a salt 
solution Figure 58e has gel fibres that create pockets of the salt solution, potentially aiding 
in the gelating process. Finally, the hydrogel of a Na2SO4 solution (Figure 58f) shows a 
relatively disperse and much more branched network. Again, this disperse network could 
explain why this gel was not stable enough to enable rheology experiments to be undertaken. 




4. Microbiological evaluation 
4.1. Antimicrobial properties 
By the year 2050, antimicrobial resistance is predicted to become the greatest threat 
to global health, directly responsible for 10 million deaths per year, overtaking the number 
of deaths caused by cancer in 2014.169 There has been a significant dip in the production and 
invention of new antimicrobial materials and agents mainly due to the high failure rate of 95 
% due to the poor market returns and lack of financial gains for big pharmaceutical 
companies.170 To date, antimicrobial resistant bacteria have been found that are resistant to 
all current marketed antimicrobial agents.171 This resistance is due to the overuse and misuse 
of antibiotics and antimicrobials, leading to bacteria forming resistance mechanisms.172 New 
antimicrobial agents are needed, ones that bypass these resistance mechanisms. 
There are two main types of bacteria, gram positive and gram negative, distinguished 
by the gram stain test. Gram positive bacteria have a singular cell membrane and a thick cell 
wall made from peptidoglycan that retains the stain, whereas gram negative bacteria have 
two cell membranes with a thin cell wall between them that does not retain the stain, and 
instead are counterstained. Methicillin-resistant Staphylococcus aureus (MRSA) (gram 
positive) and Escherichia coli (E. coli) (gram negative) are clinically relevant bacteria that 20 
– 23 were first screened against at 3.33 mM using a micro broth dilution method.173 If the 
compound inhibited more than 10 % of growth, it was taken forward to calculate MIC50. For 
the compounds that formed hydrogels, a gel plate assay was completed where 5 mg/mL in a 
0.505 M NaCl salt solution was tested against MRSA and E. coli to determine the antimicrobial 
activity of the hydrogels. All antimicrobial studies were completed by Nyasha Allen. 
4.2. Screening against E. coli and MRSA 
All compounds were screened at 3.33 mM against E. coli (Figure 59) and MRSA 
(Figure 60). Compounds 20, 21 and 23 passed screening as they killed or inhibited 10 % of 
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the bacterial growth after 700 minutes, or once the stationary phase has been reached. These 
compounds were then taken forward to calculate the minimum concentration of compound 
needed to kill or inhibit 50 % of bacteria growth (MIC50) values. Compound 22 did not pass 
screening and it is hypothesised that this is due to the lack of the benzene ring present in the 
structure. 
 
Figure 59 - Averaged growth curves created from absorbance readings of E. coli in the presence of 
different compounds. The 5 % EtOH acts as the control. 
 
Figure 60 - Averaged growth curves created from absorbance readings of S. aureus in the presence of 
different compounds. The 5 % EtOH acts as the control. 
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4.3. MIC50 calculation 
After the initial screening of the compounds, MIC50 was calculated. As only one 
biological repeat was completed, the data must be treated with caution. An overview of the 
MIC50 data is shown in Table 11. 
Table 11 – Calculated MIC50 of 20, 21 and 23. 
 E. coli (mM) MRSA (mM) Ratio (E. coli:MRSA) 
20 1.68 1.07 1:1.57 
21 1.83 a a 
23 2.54 1.14 1:2.23 
a – Data could not be calculated. 
The results from the MIC50 experiments show that 20 exhibits the greatest 
antimicrobial activity against both E. coli and MRSA. The ratio between E. coli:MRSA indicates 
if the compound could be used as a broad spectrum antimicrobial agent. Therefore, as 20 
has a very low ratio between E. coli:MRSA, this compound may be a good candidate. This 
ratio is also interesting as gram positive is often easier to kill or inhibit than gram negative, 
so as 20 has a low ratio, this model of SSA: ethyl linker with a naphthalene/aromatic unit 
would be a good route to explore further. All graphs can be found in the appendix (Figure 
S225 – S236). 
4.4. Hydrogel antimicrobial efficacy experiments 
To test the antimicrobial efficacy of the hydrogels, a series of antimicrobial surface 
disc diffusion assays were performed against E. coli and MRSA. An aliquot of ~ 50 mg of the 
hydrogel was transferred to the surface of an agar plate inoculated with either E. coli or MRSA 
and incubated at 37 °C overnight. 
If the hydrogels conferred antimicrobial activity, then a “ring” of dead bacteria (the 
zone of inhibition) would be observed. The results of the disc diffusion assay show no zone 
of inhibition on either the E. coli (Figure 61) or MRSA (Figure 62) plates. Although these 
compounds have shown to have antimicrobial properties, the concentration of SSA within 
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this sample of hydrogel is at a concentration below the calculated MIC50. As well as the 
hydrogel being below the MIC50, White et al. discussed that as the SSA forms the gel network, 
it is unable to diffuse through the agar, stopping any interactions between the SSA and 
bacteria.90 Instead, the researchers formed a hydrogel of 19 and ampicillin salt which was 
tested against both bacteria. The zone of inhibition increased by 78 % and 30 % for E. coli and 
MRSA respectively compared to the NaCl salt solution hydrogel (15 mm to 59 mm for E. coli 
and 16 mm to 23 mm for MRSA).90 All plates can be found in the appendix (Figure S237 – 
S240). 
This data implies that these hydrogels may be better suited for drug delivery rather 
than topical use antimicrobial materials themselves. 
 
Figure 61 - Disc diffusion assays showing no zone of inhibition of growth of E. coli DH5B due to the 
presence of ≈ 50 mg SSA hydrogel gel of 1-15 formed in NaCl solution (0.505 M) on the surface of the 
plate. 
 
Figure 62-- Disc diffusion assays showing no zone of inhibition of growth of MRSA USA300 due 
to the presence of ≈ 50 mg SSA hydrogel gel of 1-15 formed in NaCl solution (0.505 M) on the 




In conclusion, five novel next generation SSAs were synthesised and the self-
associated structures studied in the gas phase, solution state and solid state using a range of 
different methods. The length of the alkyl chain was determined to be an important factor in 
self-association. Increasing the alkyl chain length between the amide and sulfonate by a 
single methylene group to become an ethyl linker (CH2) causes intermolecular hydrogen 
bonding, forming a six-membered cyclic structure that competes with dimer formation. This 
cyclisation is evident in the self-association 1H NMR studies, subsequent fitting to the binding 
isotherms EK and CoEK and was also observed in the in silico data. 
Compound 23 was the only compound that formed hydrogel in salt solutions of 0.505 
M. In comparison to 19, an SSA that has been previously rheologically characterised,90 it was 
hypothesised that the difference in gelation is due to the steric effects and change in 
hydrophobicity due to the removal of the methyl group on the benzothiazole unit. 
When the antimicrobial properties of 20 – 23 were tested, 22 failed the screening 
process: it did not kill or inhibit 10 % of either E. coli or MRSA after 700 minutes. The other 
compounds were moved forward to determine MIC50 although only one biological repeat 
was performed, so the data must be treated with caution. Compound 20 was determined to 
have the lowest MIC50 for both bacteria with the lowest ratio between E.coli:MRSA, although 
23 showed 6 % difference against MRSA (20 – 1.07 mM, 23 – 1.14 mM). Further repeats 
would need to be performed to increase the validity of this data. 
A NaCl hydrogel of 23 was also screened for antimicrobial efficacy, but no zone of 
inhibition was observed. It was hypothesised that there was no zone of inhibition as the 
concentration of the hydrogel was below the MIC50 of the compound. It was also discussed 
that as the gel network is formed from the monomers of 23, it cannot diffuse through the 
agar and effectively kill or inhibit the bacteria. The same observation was also seen in 
hydrogels of 19.90 
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6. Future works 
1. Two more biological repeats will be performed to calculate valid MIC50s for 20, 21 
and 23. 
2. Compound 20 showed a relatively low ratio between E. coli:MRSA. This model of SSA 
will be explored further by increasing the alkyl chain length, which could increase 
antimicrobial efficacy against both gram positive and gram negative bacteria. 
3. As 19 has been characterised using the novel technique using a plate reader, this 
same strategy will be used for the hydrogels of 23 to help determine why this 
compound forms such different hydrogels in the salt solutions compared to 19. 
4. Previously, swapping the sulfonate to carboxylate has shown to increase the 
antimicrobial efficacy of the SSA,89 but the effect on gelation has not been discovered 
yet. A carboxylate version of 19 and 23 will be synthesised to observe the effect on 
gelation and if these compounds or hydrogels have an increased efficacy against E. 




7. Experimental techniques and synthesis 
7.1. Experimental techniques  
General remarks: A positive pressure of nitrogen and oven dried glassware were used for 
all reactions. All solvents and starting materials were purchased from known chemical 
suppliers or available stores and used without further purification. All NMR spectra were 
obtained using a Bruker AV2 400 MHz or AVNEO 400 MHz spectrometer. The data was 
processed using ACD labs or Topspin software. NMR Chemical shift values are reported in 
parts per million (ppm) and calibrated to the centre of the residual solvent peak set (s = 
singlet, br = broad, d = doublet, t = triplet, q = quartet, m = multiplet). Tensiometry 
measurements were undertaken using the Biolin Scientific Theta Attension optical 
tensiometer. The data was processed using Biolin OneAttension software. A Hamilton (309) 
syringe was used for these measurements. The melting point for each compound was 
measured using Stuart SMP10 melting point apparatus. High resolution mass spectrometry 
was performed using a Brucker microTOF-Q mass spectrometer and spectra recorded and 
processed using Brucker’s Compass Data Analysis software. Infrared spectra were obtained 
using Shimadzu IR-Affinity-1 model Infrared spectrometer. The data was analysed in 
wavenumbers (cm-1) using IRsolution software. DLS and Zeta Potential studies were carried 
out using an Anton Paar LitesizerTM 500 and processed using Kalliope TM professional. 
Rheological measurements were recorded on an Anton Parr modular compact rheometer 
(MCR302) using a cylinder probe ST10-4V-8.8/97.5. The pH was determined a Fisherbrand 
hydrous 300 pH detector and calibrated using stock buffer solution. 
Self-association constant calculation: Self-association constants were determined using 
Bindfit v0.5 (http://app.supramolecular.org/bindfit/).121 All data can be accessed online 
using the hyperlinks provided. 
Tensiometry Studies: All samples were prepared in an EtOH:H2O (1:19) solution. All 
samples underwent an annealing process in which the various solutions were heated to 
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approximately 313 K before being allowed to cool to room temperature, allowing each 
sample to reach a thermodynamic minimum. All samples were prepared through serial 
dilution of the most concentrated sample. Three surface tension measurements were 
obtained for each sample at a given concentration, using the pendant drop method. The 
average of the three values were plotted to calculate the critical micelle concentration 
(CMC).  
Mass spectrometry: Approximately 1 mg of each compound was dissolved in 1 mL of 
methanol. This solution was further diluted 100-fold before undergoing analysis where 10 
µL of each sample was injected directly into a flow of 10 mM ammonium acetate in 95 % 
water (flow rate = 0.02 mL/min). 
DLS studies: All vials used for preparing the samples were clean and dry. All solvents used 
were filtered to remove any particulates that may interfere with the results obtained. 
Samples of differing concentrations were obtained through serial dilution of a concentrated 
solution. All samples underwent an annealing process, in which they were heated to 313 K 
before being allowed to cool to 298 K to allow each sample to reach a thermodynamic 
minimum. A series of 10 runs were recorded at 298 K. 
Zeta potential studies: All vials used for preparing the samples were clean and dry. All 
solvents used were filtered to remove any particulates that may interfere with the results 
obtained. All samples underwent an annealing process, in which they were heated to 313 K 
before being allowed to cool to room temperature, allowing each sample to reach a 
thermodynamic minimum. The final zeta potential value given is an average of the number 
of experiments conducted at 298 K. 
Rheometer hydrogel preparation and experimental: Each experiment was run in triplicate. 
The appropriate aqueous salt solution (1 mL, 0.505 M) was added to 5 mg of the compound 
in a glass vial with an internal diameter of 1 cm and heated to approximately 333 K, until 
dissolved. The sample was positioned on the rheometer and set with a relaxation time of 60 
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minutes. Oscillatory amplitude experiments maintained a frequency of 10 rad s-1 and were 
performed with the amplitude of oscillation from 0.01 % up to 100 % at 298 K. Oscillatory 
frequency sweep experiments maintained a constant shear strain (γ) with an increasing 
frequency from 0.01-100 rad s-1 at 298 K. 
Hydrogel preparation: The appropriate aqueous salt solution (1 mL, 0.505 M) was added to 
the specified quantity of the compound in a glass vial and heated to approximately 333 K 
until dissolved and then left at room temperature to allow gelation to occur. Gel formation 
was achieved through an annealing process in which the pre-gel mixture was sonicated and 
heated until the gelator (23) had dissolved. At this point, the samples were sealed and 
allowed to cool to room temperature, before undergoing an inversion test for the 
formation of a hydrogel, this was then confirmed through rheological measurements. 
7.2. Chemical Synthesis 
 
Scheme 3 – The synthesis of TBA aminomethansulfonate. 
TBA aminomethansulfonate (Scheme 3): 1-Aminomethan-2-sulfonic acid (0.33 g, 3.00 mM) 
was dissolved in TBA hydroxide (1 M) in methanol (3.00 mL), excess methanol was then 
added (5 mL) before the mixture was taken to complete dryness under reduced pressure. 
Assume yield 100 %.a This compound was not characterised but used directly in the 
synthesis of compound 19, 22, 23 and 24. 
 
Scheme 4 - The synthesis of TBA aminoethansulfonate. 
 
a We assume it is 100 % as there is nothing else that can happen, the slightly basic 
conditions deprotonates the sulfonate, the released H+ then reacts with the OH- from the 
TBA, forming water and the salt. The water is then driven off on the high vac, pushing over 




TBA aminoethansulfonate (Scheme 4): 1-aminoethane-2-sulfonic acid (0.13 g, 2.00 mM) 
was dissolved in TBA hydroxide (1 M) in methanol (2.00 mL) excess methanol was then 
added (5 mL) before the mixture was taken to complete dryness under reduced pressure. 
Assume yield 100 %.b This compound was not characterised but used directly in the 
synthesis of compound 20. 
 
Scheme 5 - The synthesis of TBA aminopropansulfonate. 
TBA aminomethansulfonate (Scheme 5): 3-aminopropane-1-sulfonic acid (0.28 g, 2.00 mM) 
was dissolved in TBA hydroxide (1 M) in methanol (2.00 mL) excess methanol was then 
added (5 mL) before the mixture was taken to complete dryness under reduced pressure. 
Assume yield 100 %.c This compound was not characterised but used directly in the 
synthesis of compound 21. 
 
Scheme 6 – The synthesis of compound 19. 
Compound 19 (Scheme 6): This compound was synthesized in line with previously 
published methods.86 1H NMR (400 MHz, 298 K, DMSO-d6): δ: 0.93 (t, J = 7.44 Hz, 12H), 1.30 
(m, 8H), 1.56 (m, 8H), 2.44 (s, 3H), 3.17 (m, 8H), 3.90 (d, J = 5.76 Hz, 2H), 6.62 (s, 1H), 7.32 
(m, 1H), 7.56 (d, J = 8.87 Hz, 2H), 7.90 (m, 4H), 9.15 (s, 1H). This NMR spectrum was found 
to match previously published values.86 
 
b See footnote a. 




Scheme 7 - The synthesis of compound 20. 
Compound 20 (Scheme 7): TBA 1-aminomethan-2-sulfoniate (0.44 g, 1.20 mM) and 1-
isocyanatonapthalene (0.17 mL, 1.20 mM) were mixed in anhydrous pyridine and the 
reaction was left overnight at 338 K. The resulting solution was taken to dryness and re-
dissolved in ethyl acetate, producing the pure product as a cream powder with a yield of 82 
% (0.53 g, 0.99 mM). Melting point: 454 K; 1H NMR (400 MHz, 298 K, DMSO-d6): δ: 0.93 (t, J 
= 7.24 Hz, 12H), 1.29 (m, 8H), 1.56 (m, 8H), 2.59 (t, J = 6.44 Hz, 2H), 3.15 (m, 8H), 3.42 (q, J = 
6.6 Hz, 2H), 6.77 (t, J = 5.48 Hz, 1H), 7.40 (t, J = 7.92 Hz, 1H), 7.45 (m, 3H), 7.90 (m, 2H), 8.14 
(m, 1H), 8.82 (s, 1H); 13C{1H} NMR (100 MHz, 298 K, DMSO-d6): δ: 13.5 (CH3), 19.2 (CH2), 
23.1 (CH2), 36.3, (CH2), 51.2 (CH2), 57.5 (CH2), 116.9 (ArCH), 121.9, (ArCH), 122.0 (ArCH), 
125.2 (ArCH), 125.7 (ArCH), 125.9 (ArCH), 128.2 (ArC), 133.7 (ArC), 135.5 (ArC), 155.6 (C=O); 
IR (film): ν (cm-1) = 3282 (NH stretch), 1685 (C=O stretch), 1029 (CN stretch); HRMS for the 
sulfonate-urea ion (C13H13N2O4S-) (ESI-): m/z: act: 293.0612, [M]- cal: 293.0602 [M]-. 
 
Scheme 8 - The synthesis of compound 21. 
Compound 21 (Scheme 8): TBA 3-aminopropane-1-sulfonate (0.46 g, 1.20 mM) and 1-
Isocyanatonapthalene (0.17 mL, 1.20 mM) were added to in anhydrous pyridine and left 
overnight at 338 K in a sealed vessel. The resulting solution was taken to dryness and re-
dissolved in ethyl acetate, producing the pure product as a pale pink powder with a yield of 
78 % (0.51 g, 0.93 mM). Melting point: 428 K; 1H NMR (400 MHz, 298 K, DMSO-d6): δ: 0.93 
(t, J = 7.44 Hz, 12H), 1.30 (m, 8H), 1.56 (m, 8H), 1.75 (m, 2H), 3.18 (m, 10H), 6.64 (t, J = 5.6 
Hz, 1H), 7.40 (t, J = 7.96 Hz, 1H), 7.52 (m, 3H), 7.88 (m, 1H), 8.00 (d, J = 7.16 Hz, 1H), 8.09 (d, 
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J = 8.28 Hz, 1H), 8.53 (br s, H); 13C{1H} NMR (100 MHz, 298 K, DMSO-d6): δ: 13.5 (CH3), 19.2 
(CH2), 23.1 (CH2), 26.1 (CH2), 38.4 (CH2), 49.0 (CH2), 57.5 (CH2), 121.5 (ArCH), 121.7 (ArCH), 
125.3 (ArCH), 125.4 (ArC), 125.7 (ArCH), 125.9 (ArCH), 128.3 (ArCH), 133.7 (ArC), 135.4 
(ArC), 155.6 (C=O); IR (film): ν (cm-1) = 1690 (C=O stretch), 1032 (CN stretch); HRMS for the 
sulfonate-urea ion (C14H15N2O4S-) (ESI-): m/z: act: 307.0769, [M]- cal: 307.0758 [M]-. 
 
Scheme 9 - The synthesis of compound 22. 
Compound 22 (Scheme 9): A mixture of 2-Aminobenzothiazole (0.23 g, 1.40 mM) and CDI 
(0.27 g, 1.68 mM) were heated at reflux for 4 hours in chloroform (10.00 mL). TBA 
aminomethanesulfonate (0.49 g, 1.40 mM) was dissolved in chloroform and added to the 
original reaction mixture which was then heated at reflux overnight. The precipitate was 
removed, the filtrate taken to dryness and then dissolved in methanol (30.00 mL). The 
precipitate was removed and the filtrate taken to dryness and dissolved in ethyl acetate 
producing the pure product as a white solid with a yield of 73% (0.45 g, 0.68 mM). Melting 
point: > 473 K; 1H NMR (400 MHz, 298 K, DMSO-d6): δ: 0.92 (t, J = 7.28 Hz, 12H), 1.30 (m, 
8H), 1.55 (m, 8H), 2.37 (s, 3H), 3.15 (m, 8H), 3.93 (d, J = 5.88 Hz, 2H), 7.16 (m, 1H), 7.50 (d, J 
= 8.16 Hz, 1H), 7.66 (s, 1H), 10.54 (br s, H); 13C{1H} NMR (100 MHz, 298K, DMSO-d6): δ: 13.5 
(CH3), 19.2 (CH2), 20.9 (CH3) 23.1 (CH2), 55.9 (CH2), 57.5 (CH2), 119.4 (ArCH), 121.1 ArCH), 
127.0 (ArCH), 131.7 (ArC), 132.0 (ArC), 147.1 (ArC), 153.3 (ArC), 158.7 (C=O); IR (film): ν (cm-
1) = 3345 (NH stretch), 1697 (C=O stretch), 1038 (CN stretch); HRMS for the sulfonate-urea 




Scheme 10 - The synthesis of compound 23. 
Compound 23 (Scheme 10): A mixture of 4-(benzothiazol-2-yl)aniline (0.20 g, 0.84 mM) and 
CDI (0.17 g, 1.06 mM) was heated at reflux for 4 hours in chloroform (10.00 mL). TBA 
aminomethanesulfonate (0.30 g, 0.84 mM) was dissolved in pyridine (2.00 mL) and added 
to the original reaction mixture which was then heated at reflux overnight. The crude was 
taken to dryness, dissolved in chloroform (10.00 mL) and washed with water (10.00 mL x 3). 
The precipitate was removed, the filtrate was taken to dryness and then dissolved in ethyl 
acetate. The resulting white precipitate product with a yield of 63 % (0.34 g, 0.56 mM); 
Melting point: 468 K; 1H NMR (400 MHz, 298 K, DMSO-d6): δ: 0.93 (t, J = 7.28 Hz, 12H), 1.30 
(m, 8H), 1.56 (m, 8H), 3.16 (m, 8H), 3.90 (d, J = 5.84 Hz, 2H), 6.63 (br s, 1H), 7.49 (m, 4H), 
7.98 (m, 3H), 8.09 (d, J = 7.80 Hz, 1H), 9.17 (br s, 1H); 13C{1H} NMR (100 MHz, 298K, DMSO-
d6): δ: 13.5 (CH3), 19.2 (CH2), 23.1 (CH2), 56.0 (CH2), 57.5 (CH2), 117.6 (ArCH), 122.2 (ArCH), 
122.4 (ArCH), 25.0 (ArCH), 125.4 (ArC), 126.5 (ArCH), 128.0 (ArCH), 134.1 (ArC), 143.7 
(ArC),153.7 (ArC), 154.2 (ArC), 167.3 (C=O); IR (film): ν (cm-1) = 3267 (NH stretch), 1697 (C=O 
stretch), 1327 (S=O stretch), 1038 (CN stretch); HRMS for the sulfonate-urea ion 
(C15H12N3O4S2-) (ESI-): m/z: act: 390.2425, [M + C2H4 ]- cal: 362.0275 [M]-. 
 
Scheme 11 - The synthesis of compound 24. 
Compound 24 (Scheme 11): CDI (0.30 g, 1.82 mM) was in dissolved ethyl acetate (10.00 mL) 
and left to reflux for 1.5 hours, then TBA aminomethanesulfonate (0.64 g, 1.82 mM) in ethyl 
acetate was added to the mixture and heated at reflux overnight. The resulting precipitate 
was the product with a yield of 71 % (0.58 g, 1.20 mM); Melting point: 388 K 1H NMR (400 
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MHz, 298 K, DMSO-d6): δ: 0.93 (t, J = 7.36 Hz, 12H), 1.31 (m, 8H), 1.56 (m, 8H), 3.16 (m, 8H), 
4.02 (d, J = 6.32 Hz, 2H), 7.01 (s, 1H), 7.78 (m, 1H), 8.31 (m, 1H), 8.97 (t, J = 6.08, H); 13C{1H} 
NMR (100 MHz, 298 K, DMSO-d6): δ: 13.5 (CH3), 19.2 (CH2), 23.1 (CH2), 56.2 (CH2), 57.5 
(CH2), 116.7 (ArCH), 129.5 (ArCH), 136.1 (ArCH), 148.3 (C=O); IR (film): ν (cm-1) = 3229 (NH 
stretch), 1717 (C=O stretch), 1364 (S=O stretch), 1042 (CN stretch); HRMS for the sulfonate-
urea ion (C5H6N3O4S-) (ESI-): m/z: act: 204.0132, [M]- cal: 204.0084 [M]-. 
 
Scheme 12 - The synthesis of compound 26. 
Compound 26 (Scheme 12): This compound was synthesized in line with previously 
published methods.174 Yield of 84.9 % (0.845 g, 5.86 mM); 1H NMR (298K, 400 MHz, DMSO-
d6): δ: 5.39 (br s, 2H), 6.82 (d, J = 2.20 Hz, 1H), 6.94 (dd, J = 8.68, 2.20 Hz, 1H), 7.08 (t, J = 
7.48 Hz, 1H), 7.27 (t, J = 7.44 Hz, 1H), 7.49 (d, J = 8.22 Hz, 1H), 7.60 (m, 2H); 13C{1H} NMR 
(100 MHz, 298 K, DMSO-d6): δ: 105.8 (ArCH), 118.4 (ArCH), 120.9 (ArCH), 125.1 (ArCH), 
125.9 (ArCH), 126.3 (ArC), 127.5 (ArCH), 128.5 (ArCH), 135.0 (ArC), 146.7 (ArC). 
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9.1. Tables of data 















1986 Y 2.70 122 -101 0.50 46.05 
20 Y -4.13 x10-2 174 -13.77 c c 
21 Y 1.21 127 -24.03 c c 
22 Y 0.09 127 -42.71 32.12 44.88 
23 Y a 215 -67.13 5.16 66.97 
24 Y b b b b b 
a – Multiple association events prevent data fitting. 
b – No self-association occurs. 
c – Could not be calculated due to compound solubility. 
Table S2 – Overview of the results from quantitative 1H NMR studies. Values given in % represent 
the observed proportion of compound that became NMR silent. 
Compound 









20 0 0 31 32 
21 0 0 44 39 
22 0 0 62 a 
23 22 20 55 51 
a – Could not be calculated due to overlapping peaks. 
Table S3 – Overview of the calculated Emax, Emin and LogP, values using semi empirical PMS 
modelling methods of the anionic components of compounds 20 – 23. 
Compound Emax (kJ mol-1) Emin (kJ mol-1) LogP 
20 -721.417 -88.0876 1.05 
21 -768.478 12.0290 1.51 
22 -717.433 -48.5147 0.86 





9.2.1. Characterisation NMR 
 
Figure S1 - 1H NMR of compound 19 in DMSO-d6 conducted at 298 K. 
 
Figure S2 - 1H NMR of compound 20 in DMSO-d6 conducted at 298 K. 
 




Figure S4 - 1H NMR of compound 21 in DMSO-d6 conducted at 298 K. 
 
Figure S5 - 13C NMR of compound 21 in DMSO-d6 conducted at 298 K. 
 




Figure S7 - 13C NMR of compound 22 in DMSO-d6 conducted at 298 K. 
 
Figure S8 - 1H NMR of compound 23 in DMSO-d6 conducted at 298 K. 
 




Figure S10 - 1H NMR of compound 24 in DMSO-d6 conducted at 298 K. 
 
Figure S11 - 13C NMR of compound 24 in DMSO-d6 conducted at 298 K. 
 




Figure S13 - 1H NMR of compound 26 in DMSO-d6 conducted at 298 K. 
 
Figure S14 - 1H NMR of compound 27 in DMSO-d6 conducted at 298 K. 
  





9.2.2. qNMR experiments  
 
Figure S16 - 1H NMR spectrum (d1 = 60 s) of compound 20 (112 mM) in DMSO-d6/1.0 % DCM. 
Comparative integration indicates 0 % of the anionic component of 20 has become NMR silent. 
 
Figure S17 - 1H NMR spectrum (d1 = 60 s) of compound 21 (112 mM) in DMSO-d6/1.0 % DCM. 
Comparative integration indicates 0 % of the anionic and cationic component of 21 has become 
NMR silent. 
 
Figure S18 - 1H NMR spectrum (d1 = 60 s) of compound 22 (112 mM) in DMSO-d6/1.0 % DCM. 





Figure S19 - 1H NMR spectrum (d1 = 60 s) of compound 23 (112 mM) in DMSO-d6/1.0 % DCM. 
Comparative integration indicates 23 % of the anionic component of 23 has become NMR silent. 
 
Figure S20 - 1H NMR spectrum (d1 = 60 s) of compound 20 (5.56 mM) in D2O/5.0 % EtOH. 




Figure S21 – 1H NMR spectrum (d1 = 60 s) of compound 21 (5.56 mM) in D2O/5.0 % EtOH. 
Comparative integration indicates 44 % of the anionic component and 39 % of the cationic 
component of 21 has become NMR silent. 
 
Figure S22 - 1H NMR spectrum (d1 = 60 s) of compound 22 (0.56 mM) in D2O/5.0 % EtOH. 
Comparative integration indicates 62 % of the anionic component and 0.1 % of the cationic 
component of 22 has become NMR silent. 
 
Figure S23 - 1H NMR spectrum (d1 = 60 s) of compound 23 (5.56 mM) in D2O/5.0 % EtOH. 
Comparative integration indicates 55 % of the anionic component and 51 % of the cationic 
component of 23 has become NMR silent. 
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9.2.3. 1H NMR Self-Association Studies  
 
Figure S24 - 1H NMR stack plot of compound 20 in a DMSO-d6 0.5 % H2O solution. Samples were 
prepared in series with an aliquot of the most concentrated solution undergoing serial dilution. 
 
Figure S25 - Enlarged 1H NMR stack plot of compound 20 in a DMSO-d6 0.5 % H2O solution. 
Samples were prepared in series with an aliquot of the most concentrated solution undergoing 
serial dilution. 
8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
Chemical Shift (ppm)





Figure S26 – Graph illustrating the 1H NMR down-field change in chemical shift of urea NH 
resonances with increasing concentrations of compound 20 in DMSO-d6 0.5 % H2O solution (298 
K). 
Self-association constant calculation 
Compound 20 – Dilution study in DMSO-d6 0.5 % H2O. Values calculated from data gathered from 
both NH 1 and 2. 
Equal K/Dimerisation model 
Ke = -0.08M-1 ± -0.8800 %   Kdim = -4.13x10-2 ± -0.4400 % 
http://app.supramolecular.org/bindfit/view/67f89666-60a4-42c5-a43f-2eb9329f40be 
CoEK model 







Figure S27 - 1H NMR stack plot of compound 21 in a DMSO-d6 0.5 % H2O solution. Samples were 
prepared in series with an aliquot of the most concentrated solution undergoing serial dilution. 
 
Figure S28 - Enlarged 1H NMR stack plot of compound 21 in a DMSO-d6 0.5 % H2O solution. 
Samples were prepared in series with an aliquot of the most concentrated solution undergoing 
serial dilution. 
8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
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Figure S29 - Graph illustrating the 1H NMR down-field change in chemical shift of urea NH 
resonances with increasing concentrations of compound 21 in DMSO-d6 0.5 % H2O solution (298 
K). 
Self-association constant calculation 
Compound 21 – Dilution study in DMSO-d6 0.5 % H2O. Values calculated from data gathered from 
both NH 1 and 2. 
Equal K/Dimerisation mode 
Ke = 2.43 M-1 ± 2.0432 %   Kdim = 1.21 M-1 ± 1.0216 % 
http://app.supramolecular.org/bindfit/view/5a70f25f-8a90-483e-96a2-47f3b012057a 
CoEK model 







Figure S30 - 1H NMR stack plot of compound 22 in a DMSO-d6 0.5 % H2O solution. Samples were 
prepared in series with an aliquot of the most concentrated solution undergoing serial dilution. 
 
Figure S31 – Enlarged 1H NMR stack plot of compound 22 in a DMSO-d6 0.5 % H2O solution. 
Samples were prepared in series with an aliquot of the most concentrated solution undergoing 
serial dilution. 
11 10 9 8 7 6 5 4 3 2 1
Chemical Shift (ppm)





Figure S32 - Graph illustrating the 1H NMR down-field change in chemical shift of urea NH 
resonances with increasing concentrations of compound 22 in DMSO-d6 0.5 % H2O solution 
(298K). 
Self-association constant calculation 
Compound 22 – Dilution study in DMSO-d6 0.5 % H2O. Values calculated from data gathered from 
both NH 1 and 2. 
Equal K/Dimerisation mode 
Ke = 0.18 M-1 ± 3.7764 %   Kdim = 0.09 M-1 ± 1.8882 % 
http://app.supramolecular.org/bindfit/view/6a664418-0fe3-40cb-8e35-ab26dbb81505 
CoEK model 






9.2.4. 1H DOSY NMR experiments 
 
 
Figure S33 - 1H DOSY NMR of compound 20 (55.56 mM) in DMSO-d6 conducted at 298 K. Anionic 




Figure S34 - 1H DOSY NMR spectrum of the compound 20 (55.56 mM) in DMSO-d6 at 298 K and a 
table reporting the diffusion constants calculated for each peak used to determine the solvation 
sphere diameter of the anionic component of 20 (dH = 1.28 nm). Peaks 1 - 7 and 9 correspond to 







Figure S35 - 1H DOSY NMR of compound 21 (55.56 mM) in DMSO-d6 conducted at 298 K. Anionic 




Figure S36 - 1H DOSY NMR spectrum of the compound 21 (55.56 mM) in DMSO-d6 at 298 K and a 
table reporting the diffusion constants calculated for each peak used to determine the solvation 
sphere diameter of the anionic component of 21 (dH = 1.37 nm). Peaks 1- 6 and 8 correspond to 






Figure S37 - 1H DOSY NMR of compound 22 (55.56 mM) in DMSO-d6 conducted at 298 K. Anionic 





Figure S38 - 1H DOSY NMR spectrum of the compound 22 (55.56 mM) in DMSO-d6 at 298 K and a 
table reporting the diffusion constants calculated for each peak used to determine the solvation 
sphere diameter of the anionic component of 22 (dH = 1.29 nm). Peaks 1 - 3 correspond to the 
anionic component of 22 while peaks 4 - 7 correspond to the cationic component of 22. 
8.2.4.1. Overview 
Table S2 - Overview of diffusion coefficients (m2s-1) for compounds 20 – 23, and 25c in DMSO-d6 at 
298 K. Errors for diffusion constants are no greater than ± 1 x 10-13 m2s-1. 
 Diffusion Coefficient (m
2 s-1) 
Compound Anion TBA 
20 1.71 x 10-10 1.8 x 10-10 
21 1.60 x 10-10 1.8 x 10-10 
22 1.70 x 10-10 1.82 x 10-10 
23 a a 
a – Compound showed loss in DMSO-d6. 
Table S3 – Overview of hydrodynamic diameters (nm) for compounds 20 – 23, and 25c in DMSO-
d6 at 298 K. 
 Hydrodynamic diameter (nm) 
Compound Anion TBA 
20 1.28 1.22 
21 1.37 1.22 
22 1.29 1.20 
23 a a 




9.3. Surface tension measurements and CMC determination 
 
Figure S39 - Calculation of CMC (32.12 mM) for compound 21 in an EtOH:H2O 1:19 mixture using 
surface tension measurements. 
 
Figure S40 - Calculation of CMC (5.16 mM) for compound 23 in an EtOH:H2O 1:19 mixture using 






Table S4 - Summary CMC and surface tension at CMC. Data obtained in an EtOH:H2O (1:19) 
solution. 
Compound Zeta potential (mV) CMC (mM) Surface tension at CMC (mN/M) 
20 -13.77 a a 
21 -24.03 32.12 44.88 
22 -42.71 a a 
23 -67.13 5.16 66.97 




9.4. DLS data 
 
Figure S41 – Correlation function data for 10 DLS runs of compound 20 (5.56 mM) in an EtOH:H2O 
(1:19) solution at 298 K. 
 
Figure S42 – The average intensity particle size distribution calculated (174 nm) using 10 DLS runs 




Figure S43 – Correlation function data for 10 DLS runs of compound 20 (0.56 mM) in an EtOH:H2O 
(1:19) solution at 298 K. 
 
Figure S44 – The average intensity particle size distribution calculated (160 nm) using 10 DLS runs 




Figure S45 – Correlation function data for 9 DLS runs of compound 21 (5.56 mM) in an EtOH: H2O 
(1:19) solution at 298 K. 
 
Figure S46 – The average intensity particle size distribution calculated (127 nm) using 9 DLS runs 




Figure S47 – Correlation function data for 10 DLS runs of compound 21 (0.56 mM) in an EtOH:H2O 
(1:19) solution at 298 K 
 
Figure S48 – The average intensity particle size distribution calculated (127 nm) using 10 DLS runs 




Figure S49 - Correlation function data for 10 DLS runs of compound 22 (0.56 mM) in an EtOH:H2O 
(1:19) solution at 298 K. 
 
Figure S50 - The average intensity particle size distribution calculated (127 nm) using 10 DLS runs 




Figure S51 – Correlation function data for 10 DLS runs of compound 23 (5.56 mM) in an EtOH: H2O 
(1:19) solution at 298K. 
 
Figure S52 – The average intensity particle size distribution calculated (215 nm) using 10 DLS runs 





Figure S53 – Correlation function data for 10 DLS runs of compound 23 (0.56 mM) in an EtOH:  
H2O (1:19) solution at 298 K. 
 
Figure S54 – The average intensity particle size distribution calculated (153 nm) using 10 DLS runs 




Figure S55 - Correlation function data for 10 DLS runs of compound 23 (111.2 mM) in a DMSO 
solution at 298 K. 
 
Figure S56 - The average intensity particle size distribution calculated (4074 nm) using 10 DLS runs 





Table 5 – Summary of average intensity particle size distribution data in EtOH:H2O 1:19 solution. 
Error = standard error of the mean given to 1 dp. 
Compound Concentration (mM) Peak maxima (nm) Polydisperity (%) 
20 5.56 199.94 (± 3.1 %) 26.05 (± 0.3 %) 
 0.56 156.33 (± 1.8 %) 24.74 (± 0.5 %) 
21 5.56 153.86 (± 1.1 %) 24.67 (± 0.1 %) 
 0.56 142.49 (± 1.8 %) 24.81 (± 0.2 %) 
22 0.56 180.95 (± 2.5 %) 25.93 (± 0.2 %) 
23  5.56 255.42 (± 7.1 %) 27.37 (± 0.2 %) 
 0.56 155.46 (± 2.4 %) 15.96 (± 0.3 %) 
Table S6– Summary of average intensity particle size distribution data in DMSO. Error = standard 
error of the mean given to 1 dp. 
Compound Concentration (mM) Peak maxima (nm) Polydisperity (%) 
20 a a a 
21 a a a 
22 a a a 
23 111.12 1380.55 (± 23.17) 35.74 (± 1.4 %) 




9.5. Zeta potential data 
 
Figure S57 – The average zeta potential distribution calculated using 10 runs for compound 20 
(5.56 mM) in EtOH:H2O (1:19) solution at 298 K. Average measurement value -13.77 mV. 
 
Figure S58 – The average zeta potential distribution calculated using 10 runs for compound 21 




Figure S59 - The average zeta potential distribution calculated using 10 runs for compound 22 
(0.56 mM) in EtOH:H2O (1:19) solution at 298 K. Average measurement value -42.71 mV. 
 
Figure S60 - The average zeta potential distribution calculated using 10 runs for compound 23 





Table 7 – Summary of zeta potential at 5.56 mM for 20, 21 and 23, and 0.56 mM for 22. Data 
obtained in an EtOH:H2O (1:19) solution. 








9.6. Single Crystal X-ray Structures 
 
Figure S61 - Single crystal X-ray structure of 22: red = oxygen; yellow = sulfur; blue = nitrogen; 
white = hydrogen; grey = carbon. CCDC 2022536, C26H50N4O6S2 (M = 578.82): monoclinic, space 
group P 21/n, a = 8.4322(1) Å, b = 16.2622(2) Å, c = 23.0023(3) Å, α = 90°, β = 100.426(1)°, γ = 90°, 
V = 3102.14(7) Å3, Z = 4, T = 100(1) K, CuK\α = 1.5418 Å, Dcalc = 1.239 g/cm3, 21823 reflections 
measured (7.816 ≤ 2Θ ≤ 144.206), 6021 unique (Rint = 0.0513, Rsigma = 0.0427) which were used in 
all calculations. The final R1 was 0.0392 (I > 2σ(I)) and wR2 was 0.1069 (all data). 
Table S8 - Hydrogen bond distances and angles observed for 22, calculated from the single crystal 






length (D•••A) (Å) 
Hydrogen bond 
angle (D-H•••A) (°) 
N1 O1 3.0716(10) 3.0716(18) 
N1 O5 3.125(2) 140.8 (1) 
N2 O5 2.7277(18) 163.64 (10) 
O5 O2 2.7833(17) 173.60 (8) 
O5 O6 2.7021(19) 169.88 (10) 
O6 O1 2.8691(19) 152.52 (10) 





Figure S62 - Single crystal X-ray structure of 23: red = oxygen; yellow = sulfur; blue = nitrogen; 
white = hydrogen; grey = carbon. CCDC 1997675, C62H98N8O9S4 (M = 1227.72): monoclinic, space 
group P 2/n, a = 19.22676(16) Å, b = 13.73691(14) Å, c = 25.4779(2) Å, α = 90°, β = 107.0098(10)°, 
γ = 90°, V = 6434.76(11) Å3, Z = 4, T = 148(1) K, CuK\α = 1.5418 Å, Dcalc = 1.267 g/cm3, 42981 
reflections measured (7.256 ≤ 2Θ ≤ 133.202), 11367 unique (Rint = 0.0440, Rsigma = 0.0365) which 
were used in all calculations. The final R1 was 0.0379 (I > 2σ(I)) and wR2 was 0.1033 (all data). 
Internal angel of dimerization = 53.65(8)°. 
Table S9 - Hydrogen bond distances and angles observed for 23, calculated from the single crystal 






length (D•••A) (Å) 
Hydrogen bond 
angle (D-H•••A) (°) 
N1 O5 2.9066(19) 163.53(11) 
N2 O7 2.9093(19) 175.23(10) 
N4 O3 2.2953(19) 178.69(12) 
N5 O1 2.9089(19) 171.00(11) 
O9 O5 2.827(2) 165.38(14) 





Figure S63 - Single crystal X-ray structure of 24: red = oxygen; yellow = sulfur; blue = nitrogen; 
white = hydrogen; grey = carbon. CCDC 1997676, C21H42N4O4S (M = 446.65): monoclinic, space 
group P 21/c, a = 9.8358(6) Å, b = 15.9107(8) Å, c = 16.2624(10) Å, α = 90°, β = 89.958(6)°, γ = 90°, 
V = 2545.0(3) Å3, Z = 4, T = 148(1) K, CuK\α = 1.5418 Å, Dcalc = 1.166 g/cm3, 17127 reflections 
measured (7.774 ≤ 2Θ ≤ 133.194), 4505 unique (Rint = 0.0768, Rsigma = 0.0713) which were used in 
all calculations. The final R1 was 0.0577 (I > 2σ(I)) and wR2 was 0.1497 (all data). 
Table S10 - Hydrogen bond distances and angles observed for 24, calculated from the single 






length (D•••A) (Å) 
Hydrogen bond 
angle (D-H•••A) (°) 





9.7. Low Level in silico Modelling 
Computational calculations to identify primary hydrogen bond donating and accepting sites were 
conducted in line with studies reported by Hunter using Spartan 16’’.45 Calculations were 
performed using semi-empirical PM6 methods, after energy minimisation calculations, to identify 
Emax, Emin and LogP values. PM6 was used over AM1 in line with research conducted by Stewart. 175 
 
Figure S64 - Electrostatic potential map calculated for compound 20. Emax  and Emin values depicted 
in the Figure legends are given in kJ mol-1. 
 
Figure S65 - Electrostatic potential map calculated for compound 21. Emax  and Emin values depicted 




Figure S66 - Electrostatic potential map calculated for compound 22. Emax  and Emin values depicted 
in the Figure legends are given in kJ mol-1. 
 
Figure S67 - Electrostatic potential map calculated for compound 23. Emax and Emin values depicted 
in the Figure legends are given in kJ mol-1. 
9.7.1. Overview 
Table S11 – Summary of Emax, Emin, and LogP values for 20 – 23. 
Compound Emax (kJ mol-1) Emin (kJ mol-1) LogP 
20 -721.417 -88.0876 1.05 
21 -768.478 12.0290 1.51 
22 -717.433 -48.5147 0.86 
23 -706.202 -38.2374 1.86 
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9.8. Mass Spectrum Data 
 
Figure S68 - A high-resolution mass spectrum (ESI-) obtained for compound 20 in methanol, m/z 
[M]. 
 
Figure S69 - A high-resolution mass spectrum (ESI-) obtained for dimeric species of compound 20 





Figure S70 - A high-resolution mass spectrum (ESI-) obtained for compound 21 in methanol, m/z 
[M]. 
 
Figure S71 - A high-resolution mass spectrum (ESI-) obtained for dimeric species of compound 21 





Figure S72 - A high-resolution mass spectrum (ESI-) obtained for compound 22 in methanol, m/z 
[M]. 
 
Figure S73 - A high-resolution mass spectrum (ESI-) obtained for dimeric species of compound 22 
in methanol, m/z [M + M + H+]. 
 
Figure S74 – A high-resolution mass spectrum (ESI-) obtained for compound 23 in methanol, m/z 




Figure S75 – A high-resolution mass spectrum (ESI-) obtained for dimeric species of compound 23 
in methanol, m/z [M- + M + H+]. 
 
Figure S76 - A high-resolution mass spectrum (ESI-) obtained for dimeric species of compound 24 
in methanol, m/z [M]. 
 
Figure S77 - A high-resolution mass spectrum (ESI-) obtained for dimeric species of compound 24 




Table S12 – High resolution ESI- mass spectrometry theoretical and experimentally derived values 
of 20 – 24. 
 m/z [M] m/z [M + M + H] 
Compound Theoretical Actual Theoretical Actual 
20 293.0602 293.0612 587.1204 587.1278 
21 307.0758 307.0769 615.1516 615.1585 
22 300.0118 300.0133 300.0236 601.0319 
23 362.0275 390.2425 723.0550 723.3008 






9.9.1. Amplitude sweep 
 
Figure S78 - Graph showing average results (n=3) from amplitude sweep experiments used to 
define the linear viscoelastic region of the sample at 298 K. Compound 23 (5 mg) in 1 mL of 
aqueous NaCl solution (0.505 M) (1 = 100 %). 
 
Figure S79 - Graph showing average results (n=3) from amplitude sweep experiments used to 
define the linear viscoelastic region of the sample at 298 K. Compound 23 (5 mg) in 1 mL of 





Figure S80 - Graph showing average results (n=3) from amplitude sweep experiments used to 
define the linear viscoelastic region of the sample at 298 K. Compound 23 (5 mg) in 1 mL of 




9.9.2. The best way to conduct experiments 
 
Figure S81 - Graph showing average results (n=3) from frequency sweep experiments obtained 
from the linear viscoelastic region under a constant shear strain (γ) of 0.0277 % (298 K). Solution 
heated and gel formed around geometry. Compound 23 (5 mg) in 1 mL of aqueous NaCl solution 
(0.505 M) (1 = 100 %). 
 
Figure S82 - Graph showing average results (n=3) from frequency sweep experiments obtained 
from the linear viscoelastic region under a constant shear strain (γ) of 0.0277 % (298 K). Solution 
heated and gel formed before inserting geometry. Compound 23 (5 mg) in 1 mL of aqueous NaCl 




9.9.3. Frequency sweep 
 
Figure S83 - Graph showing average results (n=3) from frequency sweep experiments obtained 
from the linear viscoelastic region under a constant shear strain (γ) of 0.0277 % (298 K). 
Compound 23 (5 mg) in 1 mL of aqueous NaCl solution (0.505 M). 
 
Figure S84 - Graph showing average results (n=3) from frequency sweep experiments obtained 
from the linear viscoelastic region under a constant shear strain (γ) of 0.0195 % (298 K). 




Figure S85 - Graph showing average results (n=3) from frequency sweep experiments obtained 
from the linear viscoelastic region under a constant shear strain (γ) of 0.0720 % (298 K). 




9.9.4. Test of oscillatory stress 
 
Figure S86 - Graph showing average results (n=3) from amplitude sweep experiments used to 
define the linear viscoelastic region of the sample at 298 K. Compound 23 (5 mg) in 1 mL of 
aqueous NaNO3 solution (0.505 M) (1 = 100 %). 
 
Figure S87 - Graph showing average results (n=3) from frequency sweep experiments obtained 
from the linear viscoelastic region under a constant shear strain (γ) of 0.0209 % (298 K), after 
running an amplitude sweep on the same sample (Figure S86). Compound 23 (5 mg) in 1 mL of 




Figure S88 - Graph showing average results (n=3) from amplitude sweep experiments used to 
define the linear viscoelastic region of the sample at 298 K. Compound 23 (5 mg) in 1 mL of 
aqueous NaOBz solution (0.505 M) (1 = 100 %). 
 
Figure S89 - Graph showing average results (n=3) from frequency sweep experiments obtained 
from the linear viscoelastic region under a constant shear strain (γ) of 0.0174 % (298 K), after 
running an amplitude sweep on the same sample (Figure S88). Compound 23 (5 mg) in 1 mL of 




9.9.5. Sonication test 
 
Figure S90 – Sonication test at 0 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
imaged under UV irradiation (test no. 1). 
 
Figure S91 - Sonication test at 0 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S92 - Sonication test at 0 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz  
(test no. 1). 
 
Figure S93 - Sonication test at 0 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S94 - Sonication test at 5 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
imaged under UV irradiation (test no. 1). 
 
Figure S95 - Sonication test at 5 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
inverted imaged under UV irradiation (test no. 1). 
 
Figure S96 - Sonication test at 5 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S97 - Sonication test at 5 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
inverted (test no. 1). 
 
Figure S98 - Sonication test at 10 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
imaged under UV irradiation (test no. 1). 
 
Figure S99 - Sonication test at 10 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S100 - Sonication test at 10 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
(test no. 1). 
 
Figure S101 - Sonication test at 10 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
inverted (test no. 1). 
 
Figure S102 - Sonication test at 15 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S103 - Sonication test at 15 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
inverted imaged under UV irradiation (test no. 1). 
 
Figure S104 - Sonication test at 15 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
(test no. 1). 
 
Figure S105 - Sonication test at 15 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S106 - Sonication test at 20 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
imaged under UV irradiation (test no. 1). 
 
Figure S107 - Sonication test at 20 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
inverted imaged under UV irradiation (test no. 1). 
 
Figure S108 - Sonication test at 20 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S109 - Sonication test at 20 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
inverted (test no. 1). 
 
Figure S110 - Sonication test at 25 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
imaged under UV irradiation (test no. 1). 
 
Figure S111 - Sonication test at 25 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S112 - Sonication test at 25 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
(test no. 1). 
 
Figure S113 - Sonication test at 25 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S114 - Sonication test at 30 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
imaged under UV irradiation (test no. 1). 
 
Figure S115 - Sonication test at 30 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S116 - Sonication test at 30 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
(test no. 1). 
 
Figure S117 - Sonication test at 30 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S118 - Sonication test at 40 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
imaged under UV irradiation (test no. 1). 
 
Figure S119 - Sonication test at 40 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S120 - Sonication test at 40 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
(test no. 1). 
 
Figure S121 - Sonication test at 40 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S122 - Sonication test at 50 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
imaged under UV irradiation (test no. 1). 
 
Figure S123 - Sonication test at 50 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
inverted imaged under UV irradiation (test no. 1). 
 
Figure S124 - Sonication test at 50 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S125 - Sonication test at 50 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
inverted (test no. 1). 
 
Figure S126 - Sonication test at 60 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S127 - Sonication test at 60 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
inverted imaged under UV irradiation (test no. 1). 
 
Figure S128 - Sonication test at 60 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S129 - Sonication test at 60 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
inverted (test no. 1). 
 
Figure S130 - Sonication test at 0 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S131 - Sonication test at 0 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
inverted imaged under UV irradiation (test no. 2). 
 
Figure S132 - Sonication test at 0 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S133 - Sonication test at 0 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
inverted (test no. 2). 
 
Figure S134 - Sonication test at 5 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S135 - Sonication test at 5 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
inverted imaged under UV irradiation (test no. 2). 
 
Figure S136 - Sonication test at 5 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S137- Sonication test at 5 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
inverted (test no. 2). 
 
Figure S138 - Sonication test at 10 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S139 - Sonication test at 10 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
inverted imaged under UV irradiation (test no. 2). 
 
Figure S140 - Sonication test at 10 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S141 - Sonication test at 10 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
(test no. 2). 
 
Figure S142 - Sonication test at 15 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S143 - Sonication test at 15 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
inverted imaged under UV irradiation (test no. 2). 
 
Figure S144 - Sonication test at 15 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S145 - Sonication test at 15 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
inverted (test no. 2). 
 
Figure S146 - Sonication test at 20 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S147 - Sonication test at 20 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
inverted imaged under UV irradiation (test no. 2). 
 
Figure S148 - Sonication test at 20 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S149 - Sonication test at 20 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
inverted (test no. 2). 
 
Figure S150 - Sonication test at 25 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S151 - Sonication test at 25 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
inverted imaged under UV irradiation (test no. 2). 
 
Figure S152 - Sonication test at 25 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S153 - Sonication test at 25 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
inverted (test no. 2). 
 
Figure S154 - Sonication test at 30 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S155 - Sonication test at 30 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
inverted imaged under UV irradiation (test no. 2). 
 
Figure S156 - Sonication test at 30 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S157 - Sonication test at 30 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
inverted (test no. 2). 
 
Figure S158 - Sonication test at 40 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S159 - Sonication test at 40 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
inverted imaged under UV irradiation (test no. 2). 
 
Figure S160 - Sonication test at 40 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S161 - Sonication test at 40 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
inverted (test no. 2). 
 
Figure S162 - Sonication test at 50 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S163 - Sonication test at 50 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
inverted imaged under UV irradiation (test no. 2). 
 
Figure S164 - Sonication test at 50 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S165 - Sonication test at 50 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
inverted (test no. 2). 
 
Figure S166 - Sonication test at 60 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S167 - Sonication test at 60 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
inverted imaged under UV irradiation (test no. 2). 
 
Figure S168 - Sonication test at 60 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S169 - Sonication test at 60 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
inverted (test no. 2). 
 
Figure S170 - Sonication test at 0 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S171 - Sonication test at 0 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
inverted imaged under UV irradiation (test no. 3). 
 
Figure S172 - Sonication test at 0 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
(test no. 3). 
 
Figure S173 - Sonication test at 0 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S174 - Sonication test at 5 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
imaged under UV irradiation (test no. 3). 
 
Figure S175 - Sonication test at 5 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S176 - Sonication test at 5 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
(test no. 3). 
 
 
Figure S177 - Sonication test at 5 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S178 - Sonication test at 10 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
imaged under UV irradiation (test no. 3). 
 
Figure S179 - Sonication test at 10 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S180 - Sonication test at 10 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
(test no. 3). 
 
Figure S181 - Sonication test at 10 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S182 - Sonication test at 15 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
imaged under UV irradiation (test no. 3). 
 
Figure S183 - Sonication test at 15 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 





Figure S184 - Sonication test at 15 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
(test no. 3). 
 
Figure S185 - Sonication test at 15 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S186 - Sonication test at 20 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
imaged under UV irradiation (test no. 3). 
 
Figure S187 - Sonication test at 20 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S188 - Sonication test at 20 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
(test no. 3). 
 
Figure S189 - Sonication test at 20 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S190 - Sonication test at 25 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
imaged under UV irradiation (test no. 3). 
 
Figure S191 - Sonication test at 25 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S192 - Sonication test at 25 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
(test no. 3). 
 
Figure S193 - Sonication test at 25 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S194 - Sonication test at 30 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
imaged under UV irradiation (test no. 3). 
 
Figure S195 - Sonication test at 30 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S196 - Sonication test at 30 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
(test no. 3). 
 
Figure S197 - Sonication test at 30 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S198 - Sonication test at 40 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
imaged under UV irradiation (test no. 3). 
 
Figure S199 - Sonication test at 40 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S200 - Sonication test at 40 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
(test no. 3). 
 
Figure S201 - Sonication test at 40 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S202 - Sonication test at 50 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
imaged under UV irradiation (test no. 3). 
 
Figure S203 - Sonication test at 50 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S204 - Sonication test at 50 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
(test no. 3). 
 
Figure S205 - Sonication test at 50 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S206 - Sonication test at 60 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
imaged under UV irradiation (test no. 3). 
 
Figure S207 - Sonication test at 60 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 




Figure S208 - Sonication test at 60 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 
(test no. 3). 
 
Figure S209 - Sonication test at 60 minutes. Compound 23 (5 mg, 1 mL) in NaCl, NaNO3 and NaOBz 





Figure S210 – Transmitted LED microscopy image of compound 22 (5 mg/mL) in NaCl (0.505 M). 
 
Figure S211 - Transmitted LED microscopy image of a hydrogel containing compound 23 (5 




Figure S212 - DAPI LED microscopy image of a hydrogel containing compound 23 (5 mg/mL) in 
NaCl (0.505 M). 
 
Figure S213 - Transmitted LED microscopy image of a hydrogel containing compound 23 (5 




Figure S214 - DAPI LED microscopy image of a hydrogel containing compound 23 (5 mg/mL) in KCl 
(0.505 M). 
 
Figure S215 - Transmitted LED microscopy image of a hydrogel containing compound 23 (5 




Figure S216 - DAPI LED microscopy image of a hydrogel containing compound 23 (5 mg/mL) in 
NaNO3 (0.505 M). 
 
Figure S217 - Transmitted LED microscopy image of a hydrogel containing compound 23 (5 




Figure S218 - DAPI LED microscopy image of a hydrogel containing compound 23 (5 mg/mL) in 
NaH2PO4 (0.505 M). 
 
Figure S219 - Transmitted LED microscopy image of a hydrogel containing compound 23 (5 




Figure S220 - DAPI LED microscopy image of a hydrogel containing compound 23 (5 mg/mL) in 
NaOBz (0.505 M). 
 
Figure S221 - Transmitted LED microscopy image of a hydrogel containing compound 23 (5 




Figure S222 - DAPI LED microscopy image of a hydrogel containing compound 23 (5 mg/mL) in 




9.11. Biological experiments 
9.11.1 Screening 
 
Figure S223 - Averaged growth curves created from absorbance readings of E. coli in the presence 
of different compounds at 3.33 mM. The 5 % EtOH acts as the control. 
 
Figure S224 - Averaged growth curves created from absorbance readings of S. aureus in the 
presence of different compounds at 3.33 mM. The 5 % EtOH acts as the control. 
211 
 
9.11.2. MIC50 data for E. coli 
 
Figure S225 – First MIC50 biological repeat of 20. The 5 % EtOH acts as the control. 
 





Figure S227 - First MIC50 biological repeat of 21. The 5 % EtOH acts as the control. 
 





Figure S229 - First MIC50 biological repeat of 23. The 5 % EtOH acts as the control. 
 





9.11.3. MIC50 data for MRSA 
 
Figure S231 - First MIC50 biological repeat of 20. The 5 % EtOH acts as the control. 
 





Figure S233 - First MIC50 biological repeat of 21. The 5 % EtOH acts as the control. 
 





Figure S235 - First MIC50 biological repeat of 23. The 5 % EtOH acts as the control. 
 





9.11.4. Hydrogel antimicrobial efficacy experiments 
 
Figure S237 - Disc diffusion assays control on E. coli DH5B. 
 
Figure S238 - Disc diffusion assays showing the zone of inhibition of growth of E. coli DH5B due to 
the presence of ≈ 50 mg SSA hydrogel gel of 1-15 formed in NaCl solution (0.505 M) on the 
surface of the plate. 
 




Figure S240 - Disc diffusion assays showing the zone of inhibition of growth of MRSA USA300 due 
to the presence of ≈ 50 mg SSA hydrogel gel of 1-15 formed in NaCl solution (0.505 M) on the 
surface of the plate. 
